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Although tetanus is not a contagious disease, it can be deadly for people who are exposed 
and do not have protective immunity against tetanus, which can be acquired only through 
vaccination. Most studies on adult tetanus protective immunity are from high-income 
countries; limited studies occur in Africa, and none has been reported from the 
Democratic Republic of the Congo (DRC). This study sought to determine protective 
immunity against tetanus among adults in DRC in relation to their age, sex, place of 
residence, and for women, antenatal care. The primary purpose of this observational 
cross-sectional study using a nested serosurvey within the Demographic Health Survey 
was to assess protective immunity against tetanus among adults in DRC from November 
2013 to February 2014. The secondary purpose was to identify characteristics of 
populations at greatest risk of tetanus infection. The health belief model was the 
theoretical foundation for this study, and multivariate logistic regression for complex 
samples was used to analyze data from 8,602 participants. Women in the DRC were 10 
times as likely to be protected against tetanus, but both sexes ages 15–19 had lower 
immunity as teens, with 75% not protected against tetanus. As women were targeted for 
antenatal care during pregnancy, immunity against tetanus increased in women over age 
20. This evidence will allow the Ministry of Health to make informed policy decisions 
regarding adolescent and adult immunization. There is potential for positive social 
change by influencing immunization policy, providing equity in preventive health 
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Chapter 1: Introduction to the Study  
Introduction 
Tetanus is unique among vaccine preventable diseases because though it is not 
contagious, both humans and animals may be infected. This is because the bacterium that 
causes tetanus, Clostridium tetani, is found in the environment. The bacteria generally 
enter the body through a puncture wound and produce a potent neurotoxin that targets the 
central nervous system. The symptoms of tetanus often develop within 7 days of 
infection. The clinical symptoms of tetanus are distinct. A spasm of the person’s jaw 
muscles cause “lockjaw” and any stimulus, such as light or movement, will produce 
muscle spasms. These muscle spasms cause the back to arch and the arms to clench, often 
resulting in a full body spastic arch. Without swift medical attention, the symptoms of 
tetanus can result in death.  
Several decades ago, tetanus infection leading to death was common. With the 
increased use of an effective vaccine in the 1940s, there was a gradual reduction in the 
number of cases and deaths worldwide. The vaccine first reduced tetanus on the 
battlefields of major wars, and later the vaccine reduced cases of tetanus in neonates and 
children. However, as recently as 1980, there were an estimated 1 million deaths due to 
tetanus.  
Countries worldwide follow World Health Organization (WHO) 
recommendations and provide immunization for children and pregnant women against 
tetanus. Many countries in Europe and the Americas provide booster immunization for 
adolescents and adults. Some countries have surveillance systems that assess tetanus 
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immunity through serosurveys to ensure the population is protected. However, some 
countries do not routinely provide tetanus immunization for adolescents or men, and this 
leads to susceptibility of tetanus infection in this population. In developed countries, there 
are gaps in immunity to tetanus in elderly people and in women. In developing countries, 
there are limited retrospective studies and few serosurveys, but immunity gaps do exist 
and morbidity is higher in men (Aliyu et al., 2017; Chalya et al., 2011; Muteya, Kabey a 
Kabey, Lubanga, Tshamba, & Tambwe a Nkoy, 2013; Scobie et al., 2017). In the 
Democratic Republic of the Congo (DRC), vaccination is provided to children under 1 
year of age and to pregnant women. The level of protective immunity against tetanus in 
DRC was unknown prior to this research. This research filled a critical gap in knowledge 
about the actual level of protective immunity against tetanus among the adult population 
in DRC. This study addressed a significant public health problem given the high 
morbidity and mortality associated with tetanus. 
Background 
In 1967, DRC, at that time Zaire, began its first large scale immunization activity 
to eradicate smallpox by vaccinating every person in the country (Muyembe-Tamfum et 
al., 2011). DRC’s smallpox eradication program was effective. Smallpox vaccination 
together with smallpox surveillance and containment led to interruption of transmission. 
The last case of smallpox in DRC was in 1971, and globally, the last case was in Somalia 
in 1977. Global public health leaders used the momentum from the successful eradication 
of smallpox to establish an expanded program for immunization in the mid-1970s with 
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the realization that universal access to immunization was possible (Okwo-Bele & 
Cherian, 2011; WHO, 2014).  
Against this backdrop, DRC established its Expanded Programme on 
Immunization (EPI) that included the following vaccines: Bacille Calemette Guerin 
(BCG) against tuberculosis; the combined vaccine of diphtheria, tetanus, and pertussis 
(DPT); oral polio (OPV); and measles and tetanus toxoid for pregnant women in 1977 
(Mambu, 1989). Most vaccinations were administered through a mobile strategy in urban 
areas, but this shifted to fixed vaccination at health facilities in 1981 with outreach where 
facilities were not available. In 1985, to serve DRC’s population of 30 million people, the 
11 provinces of DRC were divided into 306 health zones; only 250 zones had the 
infrastructure to provide the EPI with substantial support from nongovernmental 
organizations in remote areas (Mambu, 1989).  
EPI was, and remains, an essential piece of primary health care in DRC. The 
health infrastructure now serves an estimated population of 78 million people in 26 
provinces, divided into 516 health zones. EPI is presently being provided in many of the 
8,264 primary government health centers and through private providers in urban settings 
(Ministry of Planning and Implementation of the Modern Revolution, Ministry of Public 
Health, & ICF International, 2014). There are now 10 vaccinations provided to children 
under 1 year of age. DTP has been replaced with a pentavalent vaccine, a combination of 
five vaccines—diphtheria, tetanus, pertussis, hepatitis B, and haemophilus influenza b 
(Hib)—in addition to pneumococcal vaccine (PCV), oral polio, inactivated polio (IPV), 
measles, and yellow fever with tetanus toxoid for pregnant women (Mwamba et al., 
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2017). Even with this expansion, documented improvements in national immunization 
coverage remain slow. For example, the 2013–2014 Demographic Health Survey (DHS) 
reported that 45% of DRC children 12–23 months of age completed a full vaccination 
series, and 66% of women had been adequately immunized with tetanus toxoid according 
to WHO recommendations prior to delivery, thus protecting their newborns against 
tetanus (Ministry of Planning and Implementation of the Modern Revolution et al., 2014). 
In 1986, there were an estimated 1 million global deaths due to tetanus (Roper, 
Wassilak, Scobie, Ridpath, & Orenstein, 2017), and in that year, DRC reported only 198 
cases (WHO/United Nations Children’s Fund [UNICEF], 2018). Roper et al. (2017) 
stated that most cases of tetanus occur in rural areas and are often unreported; when 
advanced medical care is not available, the fatality rate can reach 100% (Roper, 
Vandelaer, & Gasse, 2007). At the time of the 1984 census, 70% of the population of 
DRC resided in rural communities, but there has been a shift as more people moved to 
urban areas due to economic opportunity and to conflict in some parts of the country 
(Ministry of Planning and Implementation of the Modern Revolution et al., 2014).  
DRC continues to rely heavily on the donor community for financing EPI; most 
funds come from the Global Alliance for Vaccines Initiative. Little funding comes from 
the DRC national budget for routine vaccination, which has a complex process with less 
than transparent disbursement and expenditure practices (Le Gargasson, Breugelmans, 
Mibulumukini, Da Silva, & Colombini, 2013; Le Gargasson, Mibulumukini, Gessner, & 
Colombini, 2014). This practice remains despite increased donor engagement and new 
government leadership that has expressed a willingness to improve routine immunization 
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coverage in DRC. With a new president, there is a new minister of health, who may lead 
change in 2020. Domestic funding for EPI has increased over the past decade from 
$300,000 in 2002 to $2.5 million in 2010, and EPI has a permanent budget line in the 
national budget (Le Gargasson et al., 2013). 
Problem Statement  
In 1980, an estimated over 1 million cases of tetanus worldwide resulted in death 
(Roper et al., 2017). WHO maintains that only immunization can provide protection 
against tetanus and recommends that everyone should be provided lifelong protection 
against tetanus using the following vaccination regimen: three doses in the first year of 
life, with one booster at 12–23 months of age, one booster between 4 and 7 years, and 
one booster between 9 and 15 years (WHO, 2017). WHO (WHO, 2006, 2017) also 
recommends that women should receive up to five doses of tetanus vaccine beginning 
with their first pregnancy. Even with this long-standing recommendation, few developing 
countries, including DRC, have immunization programs that provide tetanus vaccine for 
adolescents and adults (Mwamba et al., 2017; WHO, 2018). 
Although tetanus is not infectious, it is deadly for those who do not have 
protective antibodies that confer immunity against the disease. Retrospective studies in 
Nigeria, Tanzania, and DRC found that 40% to 54% of adults admitted to the hospital 
with tetanus die (Chalya et al., 2011; Chukwubike & God’spower, 2009; Muteya et al., 
2013).  
Studies have been conducted predominately in high-income countries that 
measure the levels of antibody protection against tetanus. The findings of these studies 
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have been used to document levels of protective immunity and, together with 
programmatic data, support changes in immunization policy so that all citizens have the 
opportunity to maintain high levels of protective immunity against tetanus (Chen & 
Orenstein, 1996; Ölander, Auranen, Härkänen, & Leino, 2009; WHO, 2017).  
There are, however, limited studies on adult protective immunity against tetanus 
in Africa, and none has been reported in DRC. In East Africa, researchers found that in 
Tanzania and Kenya between 36% and 53% of individuals tested, respectively, did not 
have antibodies that would protect them against tetanus (Aboud, Lyamuya, Kristoffersen, 
& Matre, 2002; Scobie et al., 2017). In this study, I used data collected in the 2013–2014 
DHS in DRC together with nested serosurvey results to assess the level of protective 
immunity against tetanus among the adult population in DRC. The results of this study 
provide the first nationally representative evidence of protective immunity against tetanus 
by age, sex, and geographic location in DRC.  
Purpose of the Study  
The primary purpose of this study was to use a serosurvey to assess protective 
immunity against tetanus among adult populations in DRC between November 2013 and 
April 2014. The secondary purpose was to identify the characteristics of populations at 
greatest risk of tetanus infection based on lowered immunity levels. The dependent 
variable was protective immunity against tetanus and the independent covariables 
included age, sex, place of residence, wealth, education, and antenatal care during 
pregnancy in women.  
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Research Questions and Hypotheses 
The following are the research questions and hypotheses for this study: 
RQ1: Is there an association between age and protective immunity against tetanus 
among adults in DRC?  
H01: There is no association between age and protective immunity against tetanus 
among adults in DRC.  
Ha1: There is an association between age and protective immunity against tetanus 
among adults in DRC. 
RQ2: Is there an association between sex and protective immunity against tetanus 
among adults in DRC?  
H02: There is no association between sex and protective immunity against tetanus 
among adults in DRC.  
Ha2: There is an association between sex and protective immunity against tetanus 
among adults in DRC.  
RQ3: Is there an association between province and place of residence (urban vs. 
rural) and protective immunity against tetanus among adults in DRC?  
H03: There is no association between province and place of residence (urban vs. 
rural) and protective immunity against tetanus among adults in DRC. 
Ha3: There is association between province and place of residence (urban vs. 
rural) and protective immunity against tetanus among adults in DRC.  
RQ4: Is there an association between antenatal care and protective immunity 
against tetanus among women in DRC? 
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H04: There is no association between antenatal care and protective immunity 
against tetanus among women in DRC. 
Ha4: There is an association between antenatal care and protective immunity 
against tetanus among women in DRC.  
Theoretical Framework 
The health belief model (HBM) explains and predicts behavior based on the 
beliefs of individuals. HBM has been used in public health research and practice as the 
theoretical framework for many studies and public health interventions because it 
provides an explanation for health-seeking and preventive health behavior. Although this 
study was not specifically about changing health behavior, HBM was the theoretical 
framework for this study because the model has been used repeatedly to counsel patients, 
promote understanding, and change knowledge and attitudes of adults about different 
diseases, including tetanus (Glanz, Rimer, & Viswanath, 2008). HBM provided six 
constructs that support the decision of individuals to take preventive action against a 
defined health problem.  
In this study, the presence of antibodies against tetanus provided evidence of 
preventive action taken. The serology results provided quantitative evidence because 
antibodies against tetanus can only be acquired through vaccination. Preventive action 
occurs when a person acts from the following perceptions: (a) susceptibility to acquiring 
the disease, (b) severity of illness if acquired, (c) perceived personal benefits, (d) 
perceived barriers or negative aspects of action, (e) cues that may trigger action, and (f) a 
conviction that the individual can change behavior to achieve the desired outcome. HBM 
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continues to be widely used to support public health intervention programs, such as 
immunization and cancer prevention where the individual may be asymptomatic at the 
time of screening, and this model frames the key issues to address related to health-
seeking behavior (Glanz & Bishop, 2010). This theory suggests that if the risk of the 
disease is known, then an individual will make the choice to prevent the disease if health-
related interventions, such as immunization or screening, are available to them. Findings 
from this research study suggest this is evident for women. HBM constructs are effective 
in understanding heath behavior, and this study showed evidence of health-seeking 
behavior resulting in protective immunity against tetanus. The study results provided later 
show immunologic evidence of protection against tetanus that can only be achieved 
through immunization.  
Nature of the Study 
The nature of this study was observational, cross-sectional, and quantitative. In 
this study, I used secondary data from the DHS conducted in DRC between November 
2013 and February 2014 and data from a serosurvey nested in the DHS. Surveyors 
collected information from 19,681 households nationwide. From these households, 
interviewers gathered detailed health information from over 18,827 women ages 15 to 49 
and 8,656 men ages 15 to 59. In addition, blood samples were collected to test for tetanus 
antibody levels as well as polio, measles, mumps, and other vaccine-preventable diseases. 
I analyzed secondary data from the DHS questionnaires matched with the positive or 
negative results of the tetanus antibody assays to determine the characteristics associated 
with immunity against tetanus among adults in DRC. 
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Definition of Terms 
The following definitions are used in public health to describe terms related to 
tetanus and tetanus vaccination:  
Antenatal care: Self-reported recent service for the current pregnancy or most 
recent pregnancy from the list of possible antenatal care services, which include, but are 
not limited to, visits with skilled professionals, iron supplements, treatment for intestinal 
parasites, blood pressure screening, and vaccination with tetanus toxoid (DHS, 2013).  
Ethnicity: The self-selected tribal affiliation in DRC from those listed in the 
survey (Ministry of Planning and Implementation of the Modern Revolution, 2014).  
Immunity produced by tetanus vaccination: Vaccine-induced antibodies produced 
by b lymphocytes that can bind to a toxin that then inhibits the disease from presenting or 
developing (Roper et al., 2017). 
Immunization: A process by which a person becomes protected against a disease 
through vaccination (Centers for Disease Control and Prevention, 2018). 
Neonatal tetanus: An illness occurring in a child who has the normal ability to 
suck and cry in the first 2 days of life, loses this ability between 3 and 28 days of life, and 
becomes rigid or has spasms (WHO, 2017). It is caused by Clostridium tetani. 
Non-neonatal tetanus: An illness occurring in someone over 1 month of age with 
one or more of the following signs: trismus or lockjaw (the inability to open the mouth), 
risus sardonicus (sustained spasm of the facial muscles), or painful muscle contractions 
with a history of a wound or injury; however, tetanus may also occur in persons who are 
unable to recall a wound or injury (WHO, 2017). 
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Rural cluster: The smallest geographical survey statistical unit in the countryside 
with adjacent households selected (DHS, 2013). 
Serosurvey: The collection and testing of blood specimens from a defined 
population over a specified period to determine antibodies against a given etiologic agent 
as a direct measure of the population’s immunity. Routinely conducted serosurveys are 
referred to as serosurveillance (WHO, 2013).  
Tetanus toxoid: The vaccine administered that has a toxin produced by 
Clostridium tetani that has been rendered harmless by chemical treatment while retaining 
its antigenic activity (WHO, 2018).  
Vaccination: The process or art of introduction of a vaccine into the body to 
produce immunity to a specific disease (Centers for Disease Control and Prevention, 
2018). 
Urban clusters: The smallest geographical survey areas selected for survey, 
drawn from capital cities, large cities with populations over 1 million, small cities with 
populations over 50,000, and towns (DHS, 2013). 
Wealth: A summary of household assets documented during the DHS. Wealth is 
measured by type of flooring, water source, electricity, and possession of durable goods. 
The assets are combined to form a single index that is then divided into one of five 
ranked quintiles based on the World Bank household wealth index (DHS, 2013).  
Assumptions 
Several assumptions were made regarding the use of secondary data and nested 
serosurvey results. I assumed that the survey was conducted with the rigor afforded all 
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DHS surveys, which is well documented in the DHS manual and in the 2013–2014 DHS 
report. I assumed the participants answered honestly. I assumed the laboratory staff 
conducted the serosurvey used the assay and methodology as recommended by the 
manufacturer. I assumed the presence of tetanus antibody beyond the cut-off value for 
immunity was evidence of vaccination and protection against tetanus. Based on the DHS 
sampling and weights, I assumed that those included in the DHS and the serosurvey were 
a nationally representative sample of adults in DRC, with the few mentioned limitations. 
Based on serosurvey sample split, I assumed the samples selected for CDC’s polio study 
and the samples selected for this tetanus study were representative of the population. 
Therefore, the findings of this study can be generalized to the DHS study population and 
the population of adults of DRC.  
Scope and Delimitations 
The scope of this study was men 15 to 59 years of age and women 15 to 49 years 
of age who resided in DRC during the 2013–2014 DHS. These individuals were available 
in a household at the time of the interview and were willing to participate in the survey. 
The focus was on adult men and women because adults, except for pregnant women, are 
a neglected population regarding immunization against tetanus.  
The study was delimited in two ways: (a) limited to individuals 15 years and 
above and (b) restricted to the demographic variables listed in Table 3. The 2013–2014 
DHS for DRC contained over 17 pages of variables; I included those variables deemed 




A limitation in using secondary data is that the investigator of the secondary study 
must work with the variables operationalized for the primary study or variables derived 
through recoding or reclassification. There are also limitations in that the DHS questions 
related to antenatal care and to receiving tetanus vaccination were based on recall (Cutts, 
Claquin, Danovaro-Holliday, & Rhoda, 2016). Men and nonpregnant women were not 
asked questions on receiving tetanus vaccination. In addition, the DHS was limited to 
only those living in a house, so adults living on military bases or in hotels or adults who 
were homeless were not included in this survey (DHS, 2013).  
Significance of the Study  
This research was designed to fill a critical gap in knowledge about protective 
immunity against tetanus among the adult population in DRC, thus addressing a problem 
of public health significance given the high morbidity and mortality associated with 
tetanus disease. This study was the first nationally and provincially representative 
serosurvey for tetanus in the country and in the African subregion of WHO. This survey 
measured protective immunity against tetanus in adults across age, sex, and geographic 
location of residence. In addition, because this serosurvey was nested into the 2013–2014 
DHS, information on socioeconomic status, occupation, and additional health indicators 
examined may affect adult susceptibility to tetanus. The outcome of this study provides 
public health practitioners much needed evidence about the impact of the immunization 
program as well as immunity gaps. 
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Positive Social Change 
Currently, DRC provides tetanus vaccination for children under 1 year of age 
through the EPI program and for pregnant women during antenatal visits (Mwamba et al., 
2017). Although WHO (2017) recommendations for tetanus vaccination include one 
booster at 12–23 months of age, one booster between 4 and 7 years, one booster between 
9 and 15 years, and catch-up boosters for adults who have not been vaccinated, DRC’s 
schedule does not include vaccination for children over 1 year of age, adolescents, men, 
or nonpregnant women. This study promotes positive social change because quantitative 
data show gaps in protective immunity against tetanus and provide information on 
inequity in preventive immunization against tetanus by age and sex. This study provides 
scientific evidence to inform and shape immunization policy, support requests to 
government and donors for public health financing for immunization, and focused health 
education efforts on the susceptible populations. Finally, this study will support the 
immunization program to assess progress toward the goal of maternal and neonatal 
tetanus elimination (MNTE) because aspects of this study methodology can be 
incorporated in MNTE assessments in DRC and other countries. 
Summary 
Tetanus infections have serious consequences and are often fatal for those not 
protected by immunization. In DRC, the relatively young immunization program reached 
a small proportion of the urban population in early 1977 and expanded further in 1981. 
Data collected in the 2013–2014 DRC DHS in major urban areas, such as Kinshasa, 
include adults 36 years or younger who may have received tetanus vaccination during 
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routine immunization as an infant. Similarly, people living in the countryside and in rural 
communities who were 32 or younger may have received tetanus vaccination during 
routine immunization as an infant. People older than 36 years in urban areas and older 
than 32 in rural areas are likely never to have had the opportunity for tetanus vaccination 
as an infant. Additionally, there is no vaccination policy for older women or men in DRC.  
HBM was the theoretical framework for this study and has been used widely to 
support public health interventions. HBM is effective for understanding health-seeking 
behavior for preventive services, and in this study, there was evidence of health-seeking 
behavior, such as prenatal care during pregnancy. Over 85% of women who were 
pregnant within the past 5 years sought some type of prenatal care, and women seeking 
prenatal care were twice as likely to have protective immunity against tetanus than 
pregnant women who did not seek prenatal care.  
This observational, cross-sectional study assessed the tetanus immunity of adults 
using a nested serosurvey in DRC DHS and secondary data collected in DHS. This study 
provides scientific evidence of immunity against tetanus in adults in DRC that will allow 
the Ministry of Health and development partners to make informed policy decisions 
regarding adolescent and adult immunization. The positive social change outcome of this 
study is an influence on immunization policy providing equity in preventive health 
services in DRC, preventing death from a disease that has an efficacious vaccine.  
Chapter 2 is a review of the literature and provides an overview of the theoretical 
framework, clinical epidemiology, tetanus prevention, and measures and assessments of 
immunity. In addition, evidence of the morbidity and mortality of tetanus, through 
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surveillance and retrospective studies, is discussed. Evidence linked to serosurveys, study 
methodology, and serosurvey data from a range of countries and the contrast of immunity 
between men and women by age is reviewed. In Chapter 3, the methodology for the 
analysis of secondary data from the observational cross-sectional serosurvey is discussed 
in detail with a review of the research questions, the sampling procedures, and the sample 
size. In Chapter 4, I review each research question, the hypotheses, and the detailed 
statistical analyses. Chapter 5 is a discussion of this study’s findings and ideas for social 
change and further research, and it closes with a conclusion.  
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Chapter 2: Literature Review 
Introduction 
In 1980, over 1 million cases of tetanus worldwide resulted in death (Roper et al., 
2017). An effective vaccine can provide protection against this deadly noncommunicable 
disease. WHO maintains that only immunization with tetanus toxoid containing vaccine 
(TTCV) can provide immunological protection against tetanus. In 2006, WHO 
recommended that everyone should be provided lifelong protection against tetanus using 
the following vaccination regimens: three doses in the first year of life, one dose at four, 
one dose at 12, and a booster dose in adulthood (WHO, 2006). In 2017, WHO revised the 
global recommendations on the timing of vaccination doses to allow countries to provide 
lifelong protection against tetanus with six doses of TTCV through a routine 
immunization schedule. These revised recommendations will help reach the global goal 
of MNTE (WHO, 2017). The immunization schedule still includes three doses of TTCV 
before the age of 1, the first booster between 1 and 2 years, the second booster between 4 
and 7 years, and the third booster between 9 and 15 years of age. This is a total of six 
doses for children. In addition, WHO recommends that countries provide opportunities to 
complete the full series for those people who are not fully vaccinated during childhood. 
WHO also recommends that women, regardless of their childhood immunization status, 
receive up to five doses of TTCV beginning with their first pregnancy to protect 
newborns against tetanus because tetanus can be acquired during or following birth. 
However, few developing countries, including DRC, presently have immunization 
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programs that provide tetanus vaccine for adolescents, nonpregnant women, and adult 
men (Mwamba et al., 2017; Nanni et al., 2017; WHO, 2018). 
Although tetanus is not infectious, it is deadly for those who do not have 
protective immunity against the disease. WHO uses evidence from multiple studies that 
measure antibody levels in populations to document protective immunity against tetanus 
and to provide evidence for immunization policy changes (WHO, 2006, 2017). However, 
many of these studies are found predominately in high-income countries. There are 
limited studies on adult protective immunity against tetanus in Africa and no reported 
studies in DRC (Bourée, 2003; WHO, 2018).  
In this study, I used 2013–2014 DRC DHS data together with nested serosurvey 
results to measure protective immunity against tetanus in a nationally representative 
sample of adults in DRC between November 2013 and February 2014. For secondary 
purpose, I identified populations at greatest risk of tetanus infection (based on negative 
antibody test results) and characterized these results by age, sex, and geographic location. 
In this literature review, I examined evidence from peer-reviewed literature, book 
chapters, technical reports, and meetings proceedings that provided the theoretical 
foundation and the methodological framework for the research.  
Review Related to Content 
In this chapter I review the research literature pertaining to the content of this 
dissertation. This includes references and studies focused on HBM, the theoretical 
framework for this study; the clinical features of tetanus, including the outcomes of 
tetanus infection; and the level of protection required that forms the framework for the 
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study. I also review research studies that informed the study design and methods, 
including the operational definitions of immunity used in previous research. The review 
next considered surveillance methods that inform recent estimates of tetanus morbidity 
and mortality. These estimates provided evidence for the independent variables (age, sex, 
residence, and use of antenatal care) that were the focus of this research. The review also 
highlighted gaps in the literature regarding documented levels of protective immunity 
against tetanus among adults in Africa generally and within DRC specifically, where 
tetanus poses a significant public health problem.  
Literature Search Strategy 
For the literature search, I used electronic databases in the Walden University 
Library, including the multidata base Thoreau and CINAH & Medline, ScienceDirect, 
and SAGE Journals. I searched these databases to identify relevant books, scientific 
articles, dissertations, and other references applicable to this study. I reviewed the 
websites of the CDC, the WHO, and UNICEF for disease specific data, disease updates, 
and peer-reviewed journal articles. I also used the web search engine Google Scholar to 
identify relevant resource materials. The following key word terms were used for the 
searches: tetanus immunity, immunization for tetanus, serosurveillance, serosurvey for 
tetanus, tetanus morbidity, tetanus mortality, tetanus in adults, tetanus and immunization 
policy, the Democratic Republic of the Congo, tetanus epidemiology, tetanus 
surveillance, non-neonatal tetanus, and the health belief model.  
In the initial search, I identified papers that included these terms in the title or the 
abstract, and the search was initially restricted to papers published between 2010 and 
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2018. I amended the search to include publications prior to 2010 because a rich seminal 
body of work provided the knowledge base for tetanus vaccinology. The search also 
revealed several technical reports, meeting proceedings, abstracts, theses, and other 
published data over the past 5 years. I reviewed all relevant articles for content and for 
additional references that may have been omitted in the electronic search. I also used 
Walden library and ProQuest to search for relevant dissertations published between 2013 
and 2018 that included HBM, studies related to tetanus, or the methods used for this 
research. 
Theoretical Foundation 
The theoretical framework for this study was HBM, which provided a foundation 
for individual preventive health action. Although I did not focus the study on changing 
health behavior per se, the HBM theoretical framework has been widely used to counsel 
patients, to promote understanding, and to change knowledge and attitudes of adults 
about many conditions and diseases including tetanus (Champion & Skinner, 2008; Cutts, 
Orenstein, & Bernier, 1992). HBM was developed by Rosenstock, Kegeles, Leventhal, 
and Hochbaum, psychologists who worked with the U.S. Public Health Service in the 
1950s (Rosenstock, 1974) and focused on understanding individual behavior related to 
uptake of screening and prevention activities. Rosenstock et al.’s primary work focused 
on tuberculosis, cervical cancer, and dental diseases. Their later work focused on 
poliomyelitis (polio) and influenza. Based on their public health research, their theory 
provided insights on why healthy individuals engage in health-promoting and prevention 
behavior. Their theory was also informed by the polio outbreaks in the 1950s, and they 
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sought to determine why some individuals failed to protect themselves when a safe and 
effective vaccine was available (Rosenstock, Derryberry, & Carriger, 1959). Their 
research showed that perceived susceptibility to disease and the perceived severity of the 
disease outcome were key factors in seeking immunization. The early model asserted that 
the primary drivers of decision-making were based on perceived susceptibility to disease, 
severity of the outcome, and the belief that the recommended intervention would be 
beneficial. Early HBM focused on taking preventive actions, such as vaccination.  
Contemporary HBM contains six constructs that predict the decision of 
individuals to take preventive action against a defined health problem. The six constructs 
are based on perceived personal benefits, barriers, and threats. The relevant beliefs of the 
individual include (a) susceptibility to acquiring the disease, (b) severity of the disease, 
(c) personal benefits of intervention, (d) barriers, (e) cues which may trigger action, and 
(e) personal conviction that preventive action will lead to the desired outcome (Champion 
& Skinner, 2008). HBM has been widely used to design public health intervention 
programs such as vaccination of healthy individuals and cancer prevention where the 
individual may be asymptomatic at the time of screening (Glanz & Bishop, 2010). I used 
HBM for this study because it suggests that if the disease risk is known, then an 
individual will make a rational choice to prevent disease if the health-related 
interventions, such as vaccination or screening, are available.  
Tetanus disease has characteristics that make it amenable to the HBM framework 
given the presence of tetanus spores in both urban and rural environments; tetanus spores 
are in soil, dust, and animal intestines and feces throughout the world. This means that 
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susceptibility to tetanus spore exposure is a universal risk to all humans. The severity of 
tetanus infection is well documented by the high rates of morbidity and mortality where 
these data are captured. TTCV has been shown to be safe and effective, and most 
countries provide it for no or low cost to citizens. HBM is effective in understanding 
health-seeking behaviors, including decisions about and acquisition of immunization. In 
this study, the presence of tetanus antibodies provided evidence of preventive action, 
primarily in women of childbearing age.  
Literature Review 
Clinical Epidemiology of Tetanus 
Tetanus is caused by the toxin produced by the bacterium Clostridium tetani. 
According to CDC, tetanus spores live in the soil, and for humans, the risk of exposure is 
universal (Roper et al., 2017). In addition to soil, tetanus spores are found in the feces of 
domesticated animals, such as cows, horses, sheep, pigs, chickens, dogs, cats, and rats—
all which act as disease reservoirs. Manure used to fertilize crops or as fuel for cook fires 
potentially exposes people at risk of infection, as the spores are hardy and heat resistant. 
These spores are not susceptible to many antiseptics, including ethanol and formalin, but 
they can be neutralized by hydrogen peroxide or iodine. Tetanus spores generally enter 
the body through a break in the skin from a wound, injury, or animal bite. In neonates, 
this is generally through the umbilical cord stump following unhygienic delivery 
practices (Roper et al., 2007; Thwaites, Beeching, & Newton, 2015). Exposure has also 
been known to take place while undergoing medical or dental procedures when there are 
poor sterilization procedures. Infections with tetanus from the reuse of needles in the case 
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of injecting drug users have been well documented (Hahné et al., 2006; Roper et al., 
2017). Soil displacement coupled with injury following floods and earthquakes may also 
increase potential exposure to spores and likelihood of increasing risk of infection 
(Afshar, Raju, Ansell, & Bleck, 2011; Sutiono, Qiantori, Suwa, & Ohta, 2009; Thwaites 
et al., 2015). Given that tetanus is in the environment, anyone can be exposed to tetanus.  
The incubation period between exposure and onset of symptoms ranges from 3 to 
21 days depending on age and susceptibility of the individual. Individuals who have not 
achieved full protection from TTCV or those who have waning immunity are susceptible 
to infection if exposed (CDC, 2015; Roper et al., 2017). 
The gram-negative anaerobic spores produce a potent neurotoxin and grow well 
in oxygen-deprived environments, such as necrotic tissue. The toxin enters the nervous 
system and disinhibits motor neuron discharge causing generalized spasms. Tetanus 
diagnoses are made based on clinical findings such as history, signs, and symptoms. The 
recommendation is to begin treatment immediately. It is possible to culture Clostridium 
tetani on oxygen-reduced blood agar or meat broth, however this process takes a 
significant amount of time (Joyce, 2008).  
There are three clinical types of tetanus: generalized, cephalic, and localized 
tetanus. Symptoms of generalized tetanus include rigid jaw muscles and stiff shoulders 
and can also include adduction of arms, clenching of fists, and generalized spasms. In 
neonates, tetanus can occur following Clostridium tetani introduction through the 
umbilical cord stump. The first symptoms are often excess crying and difficulty sucking 
in infants who previously had a normal ability to suck. This is followed by trismus, 
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rigidity, and spasms. Neonatal tetanus is generalized tetanus. Cephalic tetanus generally 
follows infection during a head injury; symptoms will include lockjaw as well as eye- and 
face-related complications (Roper et al., 2007). Localized tetanus causes fixed spasms of 
muscles at the site of the injury. Most cases of tetanus are generalized (CDC, 2015). 
Tetanus Prevention 
Although tetanus toxoid was developed in 1924, the vaccine was not widely used 
in developed countries until the 1940s, when soldiers were vaccinated during World War 
II. The American Academy of Pediatrics recommended use of tetanus toxoid for infants 
in 1944. Tetanus toxoid was later combined with diphtheria toxoid and pertussis vaccine 
(CDC, 2015). The use of the combined DPT vaccine was approved in 1951 and was 
widely adopted in developed countries. After the success of the smallpox eradication 
program, in 1974 the World Health Assembly passed a resolution to establish the EPI 
intended to provide access to six critical antigens, including tetanus, for all children under 
1 year (Keja, Chan, Hayden, & Henderson, 1988). 
WHO currently recommends that people receive six doses of TTCV in their 
lifetime to provide lifelong protection against the disease. Most countries provide a series 
of three vaccinations before age 1, the first booster between 1 and 2 years, the second 
booster between 4 and 7 years, and the third booster between 9 and 15 years. Although 
policies have been developed and boosters recommended, most African countries do not 
have school-based immunization or booster programs in place, and vaccinations given to 
children above the age of 2 are not generally reported (Mihigo, Okeibunor, Anya, 
Mkanda, & Zawaira, 2017). 
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Tetanus toxoid will cause the formation of specific antitoxins instrumental in 
protecting against tetanus. Immunity to tetanus is antibody mediated with tetanus 
antitoxins belonging to the immunoglobin G (IgG) class. These antitoxins are found in 
the blood and extra vascular spaces; if tetanus toxins do enter the tissue, the antitoxins are 
well placed to neutralize the toxin produced in an infected wound. When a mother is 
actively immunized, the antitoxin can pass though the placenta to the fetus. This can 
prevent neonatal tetanus (Roper et al., 2017).  
Measures of Immunity  
Traditionally, immunization programs have measured population immunity by 
proxy using administrative data for a given vaccine. Administrative coverage is 
calculated as the number of doses provided to children within an assigned age range in a 
geographic area over a period against the estimated age-specific target population. The 
EPI program established procedures to document vaccine administration (routine 
coverage) through the maintenance of clinic-level registries and provision of vaccination 
cards to parents that record the name, date, and batch number of all vaccinations 
received. Each medical provider or clinic reports the number of vaccinations 
administered to the appropriate administrative unit, such as the district, province, or 
region, where the data are aggregated up to the national level. These administrative data 
measure routine immunization coverage and are used to estimate population immunity 
against vaccine preventable diseases for infants under the age of 1 and for women 
receiving TTCV during antenatal care. There are limitations to administrative coverage 
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both in the estimated numerator or doses given and the denominator which, in many 
countries like DRC, is a figure estimated from the last census (Sodha & Dietz, 2015).  
Country programs have also used coverage surveys to estimate routine 
immunization. During these surveys, individual households are randomly selected within 
systematically sampled (multistage or clustered) enumeration areas and the vaccination 
records of children between ages of 12–24 months and women 15–49 years of age are 
reviewed. In the absence of clinic records or vaccination cards, maternal recall is also 
used to document the number and timing of vaccinations. Maternal recall may also be 
problematic as a parent may not remember a child’s vaccination and feel pressured to 
give a positive answer which may lead to information bias resulting in increased 
coverage (Cutts, Izurieta, & Rhoda, 2013). A coverage survey may be independent and 
limited to immunization or embedded into larger population-based surveys such as the 
DHS or UNICEF’s Multiple Indicator Cluster Survey. Large coverage surveys such as 
the DHS and the Multiple Indicator Cluster Survey provide nationally representative data 
and information from children and women in both the public and private sector (Cutts et 
al., 2016; Cutts et al., 2013; UNICEF, 2015). 
Although coverage surveys are believed to offer more reliable estimates than 
routine administrative data, both survey methods share an inherent limitation where card 
retention is low (Cutts et al., 2013). The reliability of the administrative data is routinely 
questioned as the officially reported immunization rates in some regions of the world can 
be significantly higher than standardized nationally representative surveys. An analysis of 
DHS data from 45 countries compared country reports versus documented administration 
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of three doses of DPT and immunization survey findings and discovered that the official 
DPT3 coverage reported by 25 of 45 of the countries was at least 20% higher than the 
DHS while only three countries were found to be lower (Murray et al., 2003). Another 
analysis of data from 2001 found that the DRC reported coverage for DPT3 at more than 
10 million children, 1 million more than the previous year; however, data from a 
household coverage survey of the same period estimated coverage to be 500,000 less than 
what was reported (Lim, Stein, Charrow, & Murray, 2008).  
Levine suggested that biological markers are the most robust method to document 
population immunity provided that the survey methods used to collect these data are 
valid. In addition, Levine noted that underserved, high-risk communities may be 
identified through serosurveys and appropriate services can be targeted to these 
communities (Levine & Pasetti, 2016). Other researchers promote the use of 
seroprevalence surveys to monitor the effectiveness of immunization programs for 
tetanus (Cutts & Hanson, 2016; MacNeil, Dietz, & Cherian, 2014). In Ethiopia 
researchers conducted an immunization coverage survey in 3 districts reviewing clinic 
records and vaccination cards, interviewing mothers, and collecting serum from over 
1,100 children under 2 years of age. They found that traditional data sources, clinic 
records, daily vaccination sheets, individual vaccination cards, and maternal recall 
provided conflicting information and did not correlate with the objective measure of the 
serology. For example, in one district the Pentavalent-3 coverage was documented as 




Assessment of Immune Response  
Two testing techniques are used to measure immunity to tetanus: in vivo, those 
tests that take place in a living organism, and in vitro, tests that take place in test tubes or 
machines. The in vivo assay is considered the gold standard because it measures active 
antitoxin in serum. Neutralization assays are developed by injecting mice with a series of 
dilutions of sera of deadly doses of tetanus toxin. These assays are the most reliable, are 
very sensitive, and can detect neutralizing antibody at levels as low as 0.001 units per 
milliliter (IU/mL). In the 1930s, Sneath’s work led to the determination that the accepted 
level of antitoxin required for protection against tetanus is ≥ 0.01 IU/mL (WHO, 2018; 
Sneath, Kerslake, & Scruby, 1937). 
There are several in vitro assays that are in use to detect anti-tetanus antibodies; 
these are simple and relatively inexpensive, but they vary in terms of sensitivity and in 
what they measure. The passive hemagglutination test measures Immunoglobulin M 
(IgM) in red blood cells. IgM will not neutralize tetanus toxin, but there is a high 
correlation when an individual has a high level of protection. This test is rarely used 
today. The radioimmunoassay is cited but there is no evidence of use for field studies 
(WHO, 2018).  
The enzyme-linked immunosorbent assay (ELISA) is used to identify 
Immunoglobulin G (IgG) antibodies produced following immunization. This assay is one 
of the most widely used. As commercial assays do not separate active antibody and non-
neutralizing antibody, they are unable to distinguish antibodies at low levels. The 
resulting low specificity of these tests is a significant limitation in their use. The 
29 
 
threshold of current commercial tests is set between 0.1 and 0.2 IU/ml, rather than at 0.01 
IU/ml. At the higher levels the non-neutralizing antibodies are included in what is 
measured. When the cut offs are increased, there is a risk of underestimating the 
seroimmunity in populations.  
There are three in vitro tests that correlate well with in vivo testing at low titers 
and are only available for research: the competition ELISA and the Double Antigen 
ELISA (DAE)—both variations of the Elisa— and the Multi Bead Assay(MBA) 
described by Scobie (Scobie et al., 2016). There are other tests that have been recently 
approved or are in development. Dynex Technologies Multiplier chemiluminescent-
immunoassay platform is a bead assay with tetanus validated against the DAE and the 
MBA (in press). This “for research use only” approved assay, has a conservative 
protective cut off at 0.20 ≥IU/m with 80% sensitivity and 84% specificity, was used in 
this study. The Dynex measles, mumps, rubella assay was validated and the findings 
published (Higgins et al., 2019).  
Methodology for Passive Surveillance Systems for Global, Regional, and National 
Reporting  
This section describes the process of tetanus surveillance and a review of the 
global morbidity and mortality associated with tetanus. There is an examination of 
tetanus morbidity and mortality reports’ estimates from retrospective hospital reviews 
and serosurveys that focus on data found in Africa more broadly and from the DRC 
specifically. Many African countries have passive surveillance systems which rely upon 
data from clinicians in health facilities to create disease reports on a weekly or monthly 
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basis, typically as part of WHO’s Integrated Disease Surveillance System (Kasolo et al., 
2013). Unlike other vaccine preventable diseases such as measles, there is no 
confirmatory laboratory test for tetanus and so case definitions, rather than objective 
laboratory diagnostics, are used to define a case (Roper et al., 2017). In many developing 
countries where women may deliver their children at home, deaths due to neonatal 
tetanus and maternal tetanus can go unrecorded (Khan, Vandelaer, Yakubu, Raza, & 
Zulu, 2015; Thwaites et al., 2015). This is also true for adolescents and adults who may 
not have financial or geographic access to clinics. In addition, since many countries do 
not have a birth or death registry, adolescent and adult deaths due to tetanus may never be 
confirmed. Reliance of clinicians for passive reporting, the lack of a confirmatory test, 
and unreported deaths all contribute to an underrepresentation of both tetanus morbidity 
and mortality estimates. Thwaites (2015) suggested that many cases of tetanus occur in 
remote areas with limited access to health facilities resulting in both high morality of 
untreated tetanus cases and low chance of the death due to tetanus being reported. Under 
the current system in the African Region as few as 10% of cases may be reported (Mihigo 
et al., 2018). Although there is insufficient epidemiological data available to conclusively 
attribute risk of mortality by age and sex, it is well recognized that many children and 
men are unprotected against tetanus due to the lack of booster immunizations available in 
low- and middle-income countries (Thwaites & Loan, 2015).  
In 1980, WHO began collecting and publishing surveillance and vaccination 
coverage data from 195 countries on 11 vaccine preventable diseases (polio, measles, 
neonatal tetanus, non-neonatal tetanus, diphtheria, rubella, congenital rubella syndrome, 
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yellow fever, pertussis, Japanese encephalitis, and mumps). In that first year, 137 of 194 
(71%) of WHO member nations reported at least one tetanus case. In 2016, 87 countries 
(45%) reported tetanus cases, however 52 (27%) countries (including the United States) 
did not report at all (WHO, 2018). The WHO/UNICEF report does not report the number 
of morbid cases. WHO does note that the data provided is incomplete, however these 
inconsistencies highlight the challenge of working with tetanus morbidity and mortality 
data. 
Despite the discrepancies, it is generally acknowledged that substantial progress 
in reducing tetanus morbidity and mortality globally has been made. Tetanus moved from 
the 19th leading cause of death in 1990 to the 67th cause of death in 2013 (Abubakar, 
Tillmann, & Banerjee, 2015). This reduction is attributed, in part, to improved routine 
immunization coverage and childbirth practices implemented during the past two 
decades. 
This seems encouraging, yet due to underreporting these model-derived rankings 
likely underestimate the true picture. Using data collected for the global burden of disease 
study and the cause of death ensemble modeling strategy known as CODEm for global 
disease specific death estimates, researchers postulate there may have been over 56,743 
deaths globally (range 48,199 to 80,042) in 2015. Of these, approximately 19,937 
occurred in neonates, and 36,806 occurred in older children and adults (Kyu et al., 2017; 
Naghavi, Wang, & Lozano, 2015). The discrepancy between these estimates and those of 
WHO, which notified only 10,337 cases from member states in the same year, is 
approximately 140%. Even accounting for the 48 countries that did not report, the 
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difference is greater than the sum of all cases reported from India which has had the 
highest disease burden over the last decade (WHO, 2018).  
Developed countries are also still at risk for tetanus. A review of 2015 tetanus 
data published by the European Centers for Disease Control reported 117 cases from 26 
European countries whereas WHO reported 104 for the same countries that year 
(European Centre for Disease Prevention and Control, 2016). Of 117 cases 72% (84/117) 
were ≥ 65 years of age and 71% were women. Most cases occurred between the months 
of June and October, corresponding with increased outdoor activities and thus with the 
likelihood of exposure. Of the 67 cases with outcome data, there were 17 tetanus fatalities 
in individuals ranging from 5–90 years of age (European Centre for Disease Prevention 
and Control, 2016).  
In the United States between 2000 and 2008 there were 233 reported cases of non-
neonatal tetanus, 30% occurred in adults ≥ 65 with the highest mortality in this age 
group. Men accounted for 59% of all cases (CDC, 2011). In 2015, of 29 cases of tetanus 
in the United States 79% were men and 10% were over the age of 65. The majority of the 
cases were White, non-Hispanic, and between the ages of 25 and 64 (CDC, 2017). 
In 2016, there were 5,771 tetanus cases reported in the African Region of the 
WHO. The totality of cases were from 25 of the 47 AFRO member states; 11 countries 
reported zero cases and 11 did not report at all. These missing (or “silent”) areas can have 
a significant impact, particularly when the countries failing to report have a high or even 
moderately high burden of disease. For example, Angola and Central African Republic 
did not report in 2016 however they reported consistently in the five preceding years an 
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average of 498 and 62 cases respectively. These unreported cases (based on the average) 
would have contributed an additional 560 cases or 9% of the burden in the region (WHO, 
2018).  
Between 2014 and 2016, the DRC reported only neonatal tetanus cases to WHO. 
DRC reported 80, 330, 201 cases of neonatal tetanus in 2016, 2015, and respectively with 
no report for 2013. Data from the National Integrated Disease Surveillance and Response 
program in DRC suggest that in 2013 and 2014 there were approximately 1,300 and 
1,400 total cases during that period (Hoff, 2014), further underscoring the challenge 
presented by missing data. Nonetheless, findings from the global burden of disease study 
estimated non-neonatal tetanus death rates in 1990 and 2015 based on data from birth and 
death registries; verbal autopsy studies; and mortality surveillance data. The authors 
estimated a net change in mortality rates of -49.13 between 1990 to 2015. The decline in 
tetanus mortality was attributed to the increase in tetanus immunization during this period 
(Kyu et al., 2017). Overall, there is a reduction in the number of tetanus cases over the 
last several decades, however the inconsistency in tetanus reporting across countries may 
lead to under reporting. The unintended consequence is that many think the disease is not 
an issue when in fact it will continue to affect those who are most exposed due to 
livelihood.  
Surveillance Methodology: Retrospective Hospital Reviews 
In addition to country surveillance data reported to WHO, there are several 
retrospective hospital reviews that provide evidence of morbidity and mortality across the 
globe and report on factors associated with tetanus susceptibility in adult populations. 
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The methodology for these studies includes reviews of the final diagnosis classifications 
International Classification of Disease (ICD) in hospital record systems or reviews of 
hospital inpatient and outpatient registry books. Several retrospective hospital studies 
document the presence of tetanus cases in Africa. 
A retrospective hospital-based study in southern Nigeria reviewed the outcomes 
of 86 adult tetanus cases over a 10-year period from 1996 to 2005 (Chukwubike & 
God’spower, 2009). The age of cases ranged from 16–90 years; 75% were less than 40 
years of age, with a mean age of 30 years. Men accounted for 58% of the cases and 44% 
of deaths. Overall the case fatality rate was 43%. For cases above the age of 40, the case 
fatality rate (CFR) was 76%. Of the 86 cases only 10 people (eight men and two women) 
reported that they had received vaccination against tetanus.  
Similarly, in northern Nigeria a retrospective study was conducted over a 14-year 
period between 2001 and 2014 (Aliyu et al., 2017). During this time 91 tetanus cases 
were admitted to and evaluated at the Ahmadu Bello Hospital in Zaria. Of these 75% 
were men, with a median age of 14 years and 62% of the cases were under 20 years of 
age. Over 95% of cases had generalized tetanus with a CFR of 48%. There was no 
documentation of previous tetanus immunization for any of the patients. In the case notes 
there were strong recommendations given to clinicians to take every opportunity to 
review immunization records and to provide immunization to infants and boosters to 
preschool children and young adults.  
In northwestern Tanzania researchers evaluated records of cases of tetanus that 
presented to the Gilyoma teaching hospital between 2001 and 2010 (Chalya et al., 2011). 
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Of the 102 cases of tetanus during this 10-year period, 92% were men. The median age 
was 34 years and 74% of tetanus cases were less than 40 years of age. Again, the case 
fatality rate was high at 43%. This study provided information on occupation finding 
51% were farmers and 22% laborers; this is consistent with data provided by Roper et al. 
(2017) who reported higher prevalence of tetanus in occupations associated with 
agriculture. In this study 24% of cases had reported they had received tetanus vaccination 
in the past, however as tetanus vaccination is given at an early age, a booster in 
adolescence or as an adult is required to maintain protective immunity ( WHO, 2017; 
WHO, 2018). 
There is limited published data on tetanus from the DRC; however, a 
retrospective hospital review of tetanus found high mortality from patients admitted to a 
major hospital in southern DRC (Muteya et al., 2013). Between 2005 and 2009, 22 
patients were admitted with tetanus of which 95% were men. The median age was 39 and 
the CFR was 52% with a majority of patients from semi urban areas. This study was 
limited to patients admitted to the intensive care unit and the researchers thought that this 
was an under representation of the total cases seen at the hospital during the period.  
Recent tetanus deaths in adolescent boys and men between the ages of 11 and 47 
following voluntary male circumcision have highlighted the lack of tetanus immunity of 
men. Between 2012 and 2016, 13 cases of tetanus with 9 deaths were reported from 6 
countries in sub-Saharan Africa (CDC, 2016; Dalal et al., 2016). The WHO Report on 
male circumcision and tetanus in 2015 noted that many African countries focused on 
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improving infant immunization and achieving MNTE, but the goal of childhood tetanus 
booster doses for adolescents and men had not been a priority (Farley, 2015).  
In the four retrospective studies reviewed from the African region on hospital 
admissions for tetanus, men constitute most cases and deaths. These studies provide 
evidence of both morbidity and mortality from large facilities based in urban areas. What 
these studies do not provide is evidence from facilities in rural areas and there is little 
data on adolescent girls and younger women. In the next section there is a review of 
studies that provide objective quantitative evidence of protective levels of immunity 
against tetanus using serosurveys.  
Literature Related to Methods 
Developed countries, such as the United States, the Netherlands, United 
Kingdom, and Australia, have comprehensive surveillance systems for vaccine 
preventable diseases and conduct population-based surveys that use banked residual sera 
to provide evidence of immunity against vaccine preventable diseases (Wilson, Deeks, 
Hatchette, & Crowcroft, 2012). Serosurveillance has also been conducted using methods 
such as cross-sectional serosurveys or ad-hoc surveys to provide estimates of protective 
immunity or to address specific questions about disease and variables such as age and 
sex. In this section population-based surveys that have used serosurveys to determine 






Surveillance Methodology: Serosurveys  
 This section will review the serosurvey data that document tetanus antibody levels 
and factors such as age, sex, place of residence, and antenatal care. These studies 
provided the methodological foundation for this research. The studies are summarized in 
Tables 1 and 2 and listed in the order they are mentioned in the literature review. Each 
study summary includes the name of the first author, the year the study was published, 
the country in which the study was conducted, the study size, the target population, and 
the method of survey design. As there are several different assays used to measure 
tetanus immunity, the assay with the cut-off for protective immunity, key age groups of 
analysis, and prevalence findings are also presented in Tables 1 and 2. The studies are 
divided between high- to medium-income countries and medium- to low-income 
countries based on findings from the literature. The findings are discussed in the section 






Seroprevalence Studies: High- to Middle-Income Countries  
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A serosurvey of adults in Finland ≥ 30 years of age found a high level of 
protective immunity in both sexes up to 50 years of age, however immunity was higher 
among men aged 50–69 (Ölander et al., 2009). Adults ≥ 70 years were found to be 
susceptible to tetanus infection. The authors suggested that military service and higher 
rate of injury may have increased the number of tetanus immunizations among adult men, 
thus explaining the sex differential in levels of immunity between ages 50 and 70 as 
shown in Table 1. 
In Italy, a national population-based serosurvey of banked sera from routine 
laboratory testing estimated the prevalence of immunity at 71% across all age groups 
(Filia et al., 2014). However, the authors found that protective antitoxin levels declined 
steadily over time beginning in mid-life and this confirms the importance of a booster 
with waning immunity. This serosurvey confirms the low population immunity of Italian 
adults over 45 years and may explain the high incidence of tetanus reported annually.  
A prospective serosurvey on the requirement of tetanus boosters conducted in 
Taiwan also examined factors that influenced immunity (Wu et al., 2009) and found that 
anti-toxin levels declined with age. As with the Finnish study, Wu et. al. (2009) 
discovered that protective immunity levels were significantly associated with being male 
or being born after 1955, although they found no association with military service or 
working with soil or gardening.  
In Vietnam, sera were provided from a long-term general population serosurvey 
in Ho Chi Minh City (Thuy et al., 2017). A random sample of 180 men and women born 
in or before 1984 during the early years of the immunization program were selected. Of 
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the women, 73% had protective antibodies compared with 24% of the men. This cohort 
would not have had the opportunity for vaccination as infants, however women could 
have been vaccinated at antenatal clinics when pregnant or through tetanus immunization 
campaigns for women of childbearing age.  
A cross-sectional serosurvey to evaluate heath care workers immunity to 6 
vaccine preventable diseases and hepatitis C in Laos was conducted at thirteen hospitals 
throughout the country (Black et al., 2015). A majority (78%) of the participants were 
women and under 40 years of age. Serology demonstrated that 90% of women versus 
38% of men were protected against tetanus. The investigators also noted a decline in 
immunity after age 40. They attributed this decline to a “cohort effect”; the tetanus 
vaccine was introduced in 1979 so adults 34 or older were unlikely to be immunized 
against diphtheria, tetanus, and pertussis unless through a catch-up campaign. Laos has 
offered tetanus vaccine to pregnant mothers since 1991 and this practice has been 
effective as 95% of women with children had higher antibody levels.  
There are several factors that may be linked with low immunity and age in older 
adults. First, adults born before the EPI program became well established may never have 
received tetanus vaccine, and second, immunity wanes with age as has been documented 
in studies of adults (Aboud et al., 2002; Roper et al., 2017). Finally, immunization 
programs were designed to provide vaccination in most African countries during the first 
year of life and for women during pregnancy with very few countries providing 
adolescent or school-based vaccination and limited catch up immunization for those that 
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A serosurvey conducted in western Turkey among farmers aged 50 to 71 found 
protective immunity of 34% in this high exposure group (Öncü, Önde, Öncü, Ergin, & 
Öztürk, 2011). Overall 45% of men had protective immunity compared with 25% of 
women and immunity significantly declined with increasing age. Öncü et. al. (2011) 
attributed the higher immunity in men to increased injury secondary to greater physical 
activity and to risks in men leading to a higher rate of medical follow up that included 
tetanus injection.  
In a 1999 cross-sectional study of male blood donors in Dar es Salaam, Tanzania 
researchers found that 36% of men did not have protective immunity against tetanus. As 
with previous studies, middle-aged men ≥48 years of age had lower immunity levels. The 
Tanzania EPI began in 1975, therefore only individuals 18−24-years of age at the time of 
the study would have been eligible for immunization as an infant. Other people could 
have received tetanus toxoid following an injury. Overall 128 of 200 men in this study 
had protective antibodies against tetanus. The age of 47 men who were excluded from the 
analysis is unclear because they did not report a vaccination history. 
 Following the cases of tetanus in men after voluntary male circumcision in sub-
Saharan Africa between 2013 and 2016 described earlier (Dalal et al., 2016), researchers 
assessed immunity gaps in a convenience sample of children, adolescents, and women 
and men ≥ 15 years in Kenya, Tanzania, and Mozambique (Scobie et al., 2017). The 
methodology for this study was archived data and banked serum specimens or dried 
blood spots from a 2012 neglected tropical disease study. This review focused on those 
adults over 15 years of age, illustrated in Table 2. In Kenya samples were collected from 
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participants of villages in Mbita District, Homa Bay County. Overall, 91% of participants 
were seroprotected; 96% of women were seroprotected compared to 45% of men. In 
Tanzania, participants were from villages of Kongwa District, Dodoma Region. Overall 
73% of participants were seroprotected with 94% of women and 28% of men with 
protective antibodies against tetanus. Mozambique samples were collected from 
participants in 2 villages in Morrupula District, Nampula Region with 79% of individuals 
seroprotected; this included 90% of women and 64% of men. Although, this was a 
convenience sample and not generalizable to each country or to the sub-region, the study 
does provide evidence of the success of the efforts to immunize women of childbearing 
age through outreach vaccination and antenatal clinics. It is also a testament to the 
inequity of booster vaccination for the nonchildbearing sex faced with waning immunity. 
The findings do not note the protection by age to determine the immunity of adolescents, 
but for all three cohorts aged 4 to 14 overall immunity ranged from 66% to 91%, the 
highest being in Mozambique.  
In 1989, the WHO established a neonatal tetanus elimination goal, which was 
defined as < 1 case per 1000 live births, and in 1999 this initiative expanded to include 
maternal tetanus (Thwaites et al., 2015; WHO, 2017). A nationwide serosurvey was 
conducted in Cambodia in 2012 to assess the status of tetanus immunity in women of 
reproductive age aged 15 to 39 (Scobie et al., 2016). The methodology of the study was a 
cross-sectional nationally representative multistage cluster survey with a nested 
serosurvey. Of the 2,150 women tested, 88% of women were seroprotected (Table 2). 
There was no significance difference between living in a rural or urban area, however the 
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western region had 82% protection and all other regions had seroprotection of 89%. In 
women 15−19-years of age seroprotection was 63%. Although Cambodia has an 
immunization schedule that includes a booster in later childhood for adolescent girls and 
boys, uptake is suboptimal. Scobie et. al. (2016) suggests that low seroprotection in 
women 15−19 could be due to not receiving tetanus toxoid during their first pregnancy as 
97% of the parous women were seroprotected compared with 71% of the nulliparous 
women.  
In Ibadan, Nigeria, a rapid diagnostic test was used to evaluate immunity against 
tetanus in a cross-section of mothers following delivery of their first child (Orimadegun, 
Orimadegun, & Bamgboye, 2017). The methodology used for the study was a cross-
sectional design limited in geographic scope. Overall, of the 244 women aged 20−34 who 
participated in the study, 71% had protective immunity against tetanus; however, the 
older mothers aged 30−34 had the greatest immunity gap with 37% of the cohort 
unprotected. There was no significant difference in protective immunity between urban 
and rural residents and 80% of the participants were middle class with access to similar 
health facilities and reported at least 2 tetanus vaccinations during antenatal care visits in 
the current pregnancy. All participants in the study attended antenatal clinics so health-
seeking behavior was high, this study highlights missed opportunities to vaccinate.  
In summary the literature review related to methods provided evidence of several 
studies that used serology to provide evidence of immunity against tetanus. The method 
that provided the answers to this study’s research questions was an observational, cross-
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sectional, nationally representative, multistage cluster survey as described by Scobie et. 
al. (2016).  
Summary and Conclusions 
Overall, the reported morbidity and mortality from tetanus has declined globally 
with the increased use of vaccine for infants, safe delivery practices, and vaccination of 
women of childbearing age and in antenatal clinics. The data shows there are still 
additional lives to be saved and there is a safe effective vaccine that can be used for that 
purpose. In general, in high-income countries and in older age groups, women have lower 
immunity against tetanus. This is reversed in middle- and low-income countries where 
women have higher immunity than men in the older age groups. There are no studies 
comparable to Finland and Italy (Filia et al., 2014; Ölander et al., 2009) which reviewed 
cohorts of people in their 70s, but several studies did review immunity against tetanus in 
adults in middle- and low-income countries. These studies identified a greater proportion 
of women having protective immunity against tetanus than men, which was attributed to 
vaccination of women during antenatal care beginning in the mid 1970s. (Black et al., 
2015; Scobie et al., 2017; Thuy et al., 2017). 
What is striking is the high morbidity found in the retrospective studies from 
Nigeria, Tanzania, and DRC where the case fatality rate was on average 50% and men 
had the highest CFR (Aliyu et al., 2017; Chalya et al., 2011; Muteya et al., 2013). The 
limited serosurveys from Africa show that immunity against tetanus is much lower in 
men (Scobie et al., 2017). Finally, the death of 12 men in six African countries due to 
tetanus after a medical circumcision procedure to reduce their risk of HIV demonstrates 
46 
 
decreased immunity and higher risk of tetanus infection and death if exposed (Dalal et al., 
2016; Farley, 2015).  
There are limited studies on adult protective immunity levels against tetanus in 
Africa. What was unknown was the immunity to tetanus in the rural areas for younger 
women and men, and for older women who have not had children. For those groups, this 
was the first study reported in DRC. This study bridged the gap in the literature and in 




Chapter 3: Research Methods  
In this study, I used findings from the DRC DHS and nested serosurvey data 
collected between November 2013 and February 2014, to assess protective immunity 
against tetanus among adult populations in DRC. The secondary purpose of this study 
was to identify characteristics of populations at greatest risk for tetanus infection based 
on immunity against tetanus among adults in DRC. This research was designed to fill a 
critical gap in knowledge about protective immunity against tetanus among adults in 
DRC, thus addressing a significant public health problem, given the high morbidity and 
mortality associated with tetanus disease. 
This chapter includes a rationale for the study and a detailed review of the 
research design. I also address the sampling strategy and procedures for the nested 
tetanus serosurvey and the methodology for using DHS data from DRC. The chapter 
concludes with a description of potential threats to study validity and a summary of the 
ethical procedures. 
Research Design and Rationale 
In this quantitative study, I used individual-level DHS data from DRC paired with 
individual serosurvey data collected from a subset of adult survey respondents between 
November 2013 and April 2014. I chose this nested, observational cross-sectional study 
design because a nationally representative study would provide an understanding of the 
protective immunity against tetanus that is generalizable to the adult population in DRC. 
The DHS was selected because the DHS is a survey that has been used, replicated, and 
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refined over the past 34 years, thus providing reliable data output (DHS, 2013; Frankfort-
Nachmias, 2008).  
In many low-income countries, the DHS is conducted at regular intervals allowing 
for comparisons across time (Aschengrau & Seage, 2013; Creswell, 2009). The DHS 
includes questions on multiple health indicators, making it both comprehensive and cost-
effective for the countries to evaluate issues of interest across multiple sectors 
simultaneously. The nested serosurvey was designed to take advantage of the 
methodological rigor of the DHS while also reducing the costs of conducting a separate 
large survey (Manual for Serosurveys, UCLA in press).  
There is evidence that nested serosurveys have provided detailed information for 
preventable diseases in DRC. To gain insight on malaria in DRC, Taylor et. al. (2011) 
used the DHS to conduct a serosurvey in adults to gather information on the type of 
malaria present and the prevalence of each type, and Levitz et. al. (2018) evaluated the 
use of bed nets and prevalence of malaria in children. The method for gathering 
information on vaccine preventable diseases is efficient and cost effective when 
combined with a large cross-sectional study. The 2013–2014 survey was the second DHS 
carried out in DRC, so some comparisons between surveys is possible. The first DHS was 
conducted in 2007, but it did not include a nested serosurvey for immunity against 
vaccine preventable diseases (Ministry of Planning and Implementation of the Modern 
Revolution et al., 2014). 
Research designs were reviewed against the goal of this research, which was to 
use a serosurvey to assess protective immunity against tetanus among adults in DRC and 
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to identify the characteristics of those at greatest risk of tetanus infection based on 
immunity against tetanus. When considering study designs, I ruled out an experimental 
research design because the purpose of this study was not to test the impact or causal 
effect of the intervention of vaccination on the adult population. A quasi-experimental 
research design was also not appropriate because a quasi-experimental design would 
necessitate an intervention that would require the assignment of adults to a group where 
vaccination would be withheld and others to a group where vaccination would take place 
(Frankfort-Nachmias, 2008; White & Sabarwal, 2014). The efficacy of tetanus vaccine is 
well understood as well as the consequence of exposure to tetanus; therefore, it would be 
unethical to knowingly withhold vaccine for research purposes (WHO, 2018).  
By contrast, the observational cross-sectional survey design is nonexperimental; 
the benefit of this approach was that it did not require random assignment of individuals 
to an intervention. This was a significant advantage because withholding an effective 
intervention such as tetanus vaccine would be unethical (Frankfort-Nachmias, 2008). 
Therefore, the use of secondary data gathered from an observational cross-sectional 
survey design was both ethical and efficient.  
The variables were selected for this study based on the research questions and the 
literature review. The dependent variable for this study was protective immunity against 
tetanus. The independent covariables were age, sex, province, place of residence, wealth, 
education, antenatal visits during pregnancy, and tetanus vaccination when pregnant. The 
following were the research questions and hypotheses for this study: 
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RQ1: Is there an association between age and protective immunity against tetanus 
among adults in DRC?  
H01: There is no association between age and protective immunity against tetanus 
among adults in DRC.  
Ha1: There is an association between age and protective immunity against tetanus 
among adults in DRC. 
RQ2: Is there an association between sex and protective immunity against tetanus 
among adults in DRC?  
H02: There is no association between sex and protective immunity against tetanus 
among adults in DRC.  
Ha2: There is an association between sex and protective immunity against tetanus 
among adults in DRC.  
RQ3: Is there an association between province and place of residence (urban vs. 
rural) and protective immunity against tetanus among adults in DRC?  
H03: There is no association between province and place of residence (urban vs. 
rural) and protective immunity against tetanus among adults in DRC. 
Ha3: There is association between province and place of residence (urban vs. 
rural) and protective immunity against tetanus among adults in DRC.  
RQ4: Is there an association between antenatal care and protective immunity 
against tetanus among women in DRC? 
H04: There is no association between antenatal care and protective immunity 
against tetanus among women in DRC. 
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Ha4: There is an association between antenatal care and protective immunity 
against tetanus among women in DRC.  
Methodology 
The survey population for this research was drawn from all women ages 15 to 49 
and men ages 15 to 59 in DRC (Ministry of Planning and Implementation of the Modern 
Revolution et al., 2014). The most recent population-based census was conducted in DRC 
in 1984, and the population was estimated at 30.7 million with 70% of DRC inhabitants 
residing in rural areas. Using data from 1984 census and an estimated population growth 
rate of 3%, the DRC National Institute of Statistics prepares annual population 
projections. At the time of DHS preparations in 2012, the National Institute of Statistics 
(2011) estimated the size of the population of DRC to be 77.8 million people. 
In 2006, DRC’s constitution was amended and the number of administrative 
provinces was slated for increase from 11 to 26 with further subdivisions into cities and 
districts. The cities are urban and further divided into communities, and the districts are 
rural divided into territories. The implementation of this division began in 2015, and the 
DHS technical team designed the survey with sufficient power for all questions in the 
provinces, ensuring the DRC DHS was both provincially and nationally representative. 
(Ministry of Planning and Implementation of the Modern Revolution et al., 2014).  
Sample and Sampling Procedures 
The DHS is well-established with a sampling manual developed by the firm ICF 
International to promote rigor, precision, and replicability in the survey methodology 
(DHS, 2013). This cross-sectional survey uses a stratified multistage cluster design, 
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where stratification reduces variations in estimates for specified subgroups (Frankfort-
Nachmias, 2008). The DRC DHS used probability sampling to allow for accurate 
estimates of population parameters giving each sampling unit in the survey a known 
probability of being included (DHS, 2013). The sampling frame is the comprehensive list 
of all units or subjects that are included in the target population (DHS, 2013; Frankfort-
Nachmias, 2008). According to the DHS manual, an up-to-date and comprehensive 
sampling frame is critical for an unbiased assessment. The DRC conducted the Multiple 
Indicator Cluster Survey in 2010 was considered to have a reliable sampling frame 
(National Institute of Statistics, 2011) and data gathered during the 2012 1-2-3 Survey 
(Employment, Informal Sector, and Household Consumption) provided additional 
information on the sampling frame in province and rural areas (Ministry of Planning and 
Implementation of the Modern Revolution, 2014). The sampling frame used for the DHS 
combined previous survey data with 2013 projected National Institute of Statistics 
population figures and government administrative and electoral census data (DHS, 2013).  
This survey had a two-stage stratified cluster design. In the first stage, each 
province had a cluster of samples selected independently in each district with the 
probability of the cluster being selected proportional to its population size; then all 
households within each selected cluster were listed. During the second stage, households 
for interview were selected by equal probability through systematic sampling at the 
cluster level. Substitute clusters were preselected, in case of violence, war, civil 
disturbance, or natural disaster. 
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The sample size for the DRC DHS was calculated based on the estimated number 
of households required for the desired precision of the key indicators required for the 
women’s questionnaires for both fertility and mortality and HIV. For the 11 provinces, 
this was 1,000 women per province, and for the 26 new provinces, this was 500 women 
per province. The final sample size ranged from 500 to 1,500 women per province 
(Ministry of Planning and Implementation of the Modern Revolution et al., 2014).  
In this study 540 clusters were selected nationwide with 379 rural clusters and 
161 urban clusters (Figure 1). Teams visited 34 households in each cluster. Due to 
insecurity, four clusters were not visited, two in Katanga, one in Kasai Orientale, and one 
in North Kivu, these clusters were not replaced because of ongoing security challenges 




Figure 1. Map of DRC: Provinces with 2013–2014 DHS urban and rural clusters. 
Nationwide, 19,681 households were visited, and 18,827 women aged 15 to 49 
and 8,656 men aged 15 to 59 were interviewed. Men were only eligible to be selected 
into the sample in half the selected households whereas women were able to be 
interviewed in every household which could be the rational for the increasing the age in 
men. The men and women in households in which men were selected for interview were 
eligible for all serologic testing including HIV, malaria, and immunity against vaccine 
preventable diseases. Of the serologic samples collected, approximately 50% were 
selected for polio testing at the CDC and the other 50% of samples were tested in the 
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DRC for immunity against tetanus, measles, rubella, mumps, and chicken pox. The 
available samples were split into two equally representative sub-sets of the sample and of 
the population from which it was drawn as follows: within each cluster and province, 
samples were sorted by age and sex to form pairs of men and pairs of women, with one 
half of each pair being randomly selected for polio neutralizing antibodies at CDC. 
Singletons were assigned with 50% probability of assignment to CDC or DRC. In 
correspondence with researchers at the Kinshasa School of Public Health (KSPH) and the 
University of California at Los Angeles (UCLA), 8,713 samples were sent to CDC for 
testing for polio 8,706 remained for the tetanus serosurvey; statistician Dale Rhoda 
provided guidance on the sample split (personal correspondence, May 2018). Among the 
8,706 samples listed as available for testing 132 were duplicate records, 305 had no 
corresponding interview data and 149 had insufficient blood for testing leaving 8,120 




Figure 2. Flow diagram of samples available for tetanus serology. 
The sample for the observational cross-sectional study on tetanus immunity was 
drawn from a subpopulation of the adults who were available for testing from the DRC 
DHS. The appropriate sample size was identified for the study on the factors associated 
with tetanus immunity among the adult population in the DRC using G*Power software 
version 3.1.9.2 (Faul, Erdfelder, Lang, & Buchner, 2007). In initial sample size 
calculation, attention was given to (a) alpha (α), the risk of making a type I error and 
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incorrectly rejecting the null hypothesis of significance, (b) beta (β), statistical power, the 
probability of rejecting the null hypothesis when it should be, and (c) effect size. 
The effect size is the standardized measure of the extent of the observed effect 
which can be set at 0.10 for a small effect, 0.30 for a medium effect or 0.50 for a large 
effect size which would account for 25% of the effect (Cohen, 1992; Field, 2013). 
G*Power was used to calculate the initial sample size with a medium effect size of 0.3, α 
of 0.05 and statistical power of 0.80 (Type II error rate β = 0.20). The sample size for the 
study was 143 and the sample size was doubled per province to answer the primary 
research question of the association between immunity against tetanus and sex. At the 
time of the DHS there were 11 provinces, therefore the national sample required would 
be 3,146 participants for this study. After the data were received and cleaned, there were 
8,120 samples with associated information available for the study. At this time the 
administrative structure changed there were 26 provinces and I made the decision to 
conduct the final analysis for the 26 new provinces. The final provincial unweighted 
sample size ranged from 201 to 701 participants. G*Power was used to calculate the 
statistical power, with a minimum sample size of 201particapants per province, α of 0.05, 
and effect size of 0.3. The statistical power was 0.9122 and the study sample size was 
sufficient for generalization. 
Procedures for Archival Data 
I followed the procedures outlined for archival data. To access the adult DRC 
DHS data, I received permission from the DHS program through the website 
https://dhsprogram.com/data/new-user-registration.cfm. To access the tetanus serology 
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data, I received permission from UCLA following a written request and agreement to 
share all analysis.  
Operationalization of Variables 
The dependent variable for this study was protective immunity against tetanus. 
Independent demographic variables were age, sex, province, and urban or rural residence. 
Age was recorded as the age at the time of interview as a continuous variable and re-
coded in 5–year increments beginning at age 15. Additional covariates such as marriage, 
education, literacy, ethnicity, occupation, having health insurance, and religion were 
included in the analysis. There were specific variables for women that included antenatal 
visits within the past 5 years, number of children ever born, births in last 5 years, and 
number of tetanus vaccinations before last pregnancy. Table 3 summarizes the variables, 







Variable Type Definition Measure/code 
Dependent variable 
   
Tetanus immunity Binary Not protected 0 
Protected 1 
Independent variables 
   
Sex Binary Male 0 
Female 1 











 Continuous 15-59 15-59 
Province Categorical 
nominal 
26 provinces 1 to 26   
Type of residence Categorical  Urban 1 
nominal Rural 2 
Education Categorical 
ordinal 











Ethnicity  Categorical 
nominal 
BasKasai & KwiluKwngo 12 
Cuvette Central 13 
Ubangi & Itimbiri 14 
Uele Lac Albert 15 
Basele-K, Man. & Kivu 16 
Kasai, Katanga, Tanganika 17 
Lunda, Pygme, other  18 
Occupation Categorical 
nominal 









Variable Type Definition Measure/code 
Health insurance status Binary No 0 
Yes 1 
Literacy Categorical  
ordinal 
Cannot read at all 0 
Read part of sentence 1 
Read whole sentence 2 
Not assessed 3 
Marital status Categorical  
nominal 
Not Married  0 
Married 1 
Living with Partner 2 
Widowed/divorced  3 
Not Living with Partner  4 
Religion Categorical 
nominal 
No religion 0 
Catholic 1 
Protestant 2 
Local Religion 3 
Other - Christian 4 
Muslim 5 
Women’s births in  
the last 5 years 
Categorical 
ordinal 





Women’s prenatal visit 
to any provider 
Binary No 0 
Yes 1 




No visit 0 
Facility based staff 1 
Others 2 
Combined 3 




 10-14 1 
 15-19 2 
 20-24 3 
 25-29 4 
 30-42 5 
Women’s reported # TT 







Do not know 8 












Data Analysis Plan 
Data received from the DHS program was transformed into a SPSS dataset and a 
codebook was developed with variables named and each variable coded. The data were 
reviewed for missing variables and decisions were made on values that were missing, 
small in number, or that contained inconsistent data. Following this process literacy, 
religion, and occupation were recoded and the variable for the number of years since a 
tetanus vaccination was not used. One variable response had missing data, 0.2% of the 
variable “literacy “was missing. The missing data for literacy was imputed as “not 
assessed” to allow the variable to be included in the analysis. Each variable was named 
and codes updated as modifications were made.  
The data from this study was analyzed using IBM SPSS version 25. Sample 
weights and strata were obtained from the 2013–2014 DRC DHS data set from which the 
data were drawn and incorporated into the SPSS complex sample design module. The 
sample design module incorporated the strata, clustering, and sample weight of the 
survey and was then used for all the analysis.  
Univariate analysis was conducted to understand the distribution, central 
tendency, and dispersion of the variables. Categorical variable analysis included the 
percentage and 95% confidence intervals (CI ; binary, ordinal, nominal). For the 
continuous variable age shown on Table 3, the mean, median, range, and 95% confidence 
intervals are described. Immunity against tetanus was stratified by all variables to review 
susceptibility and identify trends and gaps in immunity among subgroups. In this study 
Rao-Scott chi square tests, which account for the DHS study design, were used to identify 
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demographic characteristics that were significantly associated with protective immunity 
against tetanus at p < 0.05 (Rao & Scott, 1984 ; Appendix A, Tables A1-A3). These 
variables were considered for inclusion in the multivariate logistic regression model. 
Variables that were not statistically significantly associated with the dependent variable 
were reviewed and removed from the model.  
Covariates were tested using Pearson’s rho to identify covariates that are 
correlated and then one of the pairs that were found to be correlated were not entered in 
the final model. Literacy was significantly correlated to education rho = .803, p = .001 
and literacy was excluded from the model. Descriptive analysis was conducted to 
describe all variables and their features.  
Variables with the strongest association described above were included in the 
multivariate model. The logistic regression model was created using the complex sample 
module recommended by DHS statisticians (Croft, Marshall, & Allen, 2018). The final 
models contained predictors that were significant at the threshold of p < 0.05. Results 
from the multiple logistic regression model are displayed using adjusted odds ratios 
(AOR) with p values and confidence intervals in Tables 8 and 9. 
Threats to Validity 
In this study, archived data from a large cross-sectional nationally representative 
survey that used a stratified cluster sampling design were analyzed. Threats to internal 
validity are more common in studies with experimental designs where researchers are 
faced with various threats to intervention groups such as death, extreme scores, and 
familiarity with test instruments that may affect the outcome; all or some of them may 
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call into question the cause and effect of the design. For experimental research, measures 
can be built into the study design to counter these threats (Creswell, 2009; Trochim, 
Donnelly, & Arora, 2015).  
This study did not try to establish a causal effect because immunity against 
tetanus following the recommended vaccination schedule has already been established 
(Roper et al., 2017). A nonexperimental, quantitative, observational cross-sectional 
survey using probability sampling did not have the experimental design threats to internal 
validity. Based on DHS sampling methods of the study design, this study avoided the 
internal validity threats of selection and information bias. The updated sampling frame 
minimizes the risk of selection bias which can happen if the sampling frame is outdated 
and nonrepresentative of the current population. The use of probability sampling ensured 
random selection and preselection of clusters at the central coordination unit minimized 
selection bias, which can happen when field staff select easily accessible clusters or 
households (Cutts et al., 2013). It is also a general health and household survey so 
participants may be more likely to take part than if this were for a specified health 
outcome, due to rumors, misconceptions, or myths. Finally, the serosurvey sample split 
was conducted to avoid selection bias through the rigorous randomized division process. 
Information bias may occur as information gathered on adult immunization against 
tetanus was based on recall; however, survey enumerators were well trained and spoke 
the local language to enable the respondent to feel at ease and not pressured for an 
assumed answer (Cutts et al., 2013; DHS, 2013).  
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External validity threats occur when researchers generalize study findings well 
beyond the study to other groups, places, or times that were not intended. This happens 
when there are unique characteristics of the sample or the setting and unreproducible 
features in the study design (Creswell, 2009; Trochim et al., 2015). External validity had 
the potential to be a legitimate threat to the study. However, to minimize threats to 
external validity, the study had a representative sample at national and provincial levels, 
and the stratified selection of clusters were incorporated into the study design and 
analysis. While this study may not be generalizable to all countries in central Africa, the 
DHS has been replicated in over 90 countries improving the comparability of 
immunization data; recent serosurveys and the literature review suggest a pattern found in 
other countries in sub-Saharan Africa (Scobie et al., 2017). The DHS began in 1984 and 
since then over 300 surveys have been conducted (ICF International, 2018). The DHS is a 
nationally representative survey providing data on health and populations using specific 
modules or questionnaires on child health, family planning, reproductive health, nutrition, 
and more. These large surveys are conducted about every 5 years in low- and middle-
income countries and generally include 5,000 to 30,000 households per country based on 
population size. Modifications are allowed, but they are kept to a minimum to maintain 
comparability and to limit the complexity of an already lengthy questionnaire. The data 
collected by DHS can be comparable across countries. This is because DHS uses standard 
model questionnaires including the DHS Model Household Questionnaire, the DHS 
Model Woman’s Questionnaire, and the DHS Model Men’s Questionnaire (DHS, 2013).  
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To ensure data were gathered correctly, consistently, and with continuous quality 
supervision, the DHS had an extensive training program for supervisors on survey 
implementation and intensive training for interviewers (Hancioglu & Arnold, 2013; 
Ministry of Planning and Implementation of the Modern Revolution et al., 2014). 
Training materials were continuously reviewed and updated by subject matter experts 
supported by ICF and international partners. Data were double entered into a database 
designed for the questionnaire that had consistency checks and computation of sampling 
errors. Data were checked while the teams were in the field so errors could be corrected. 
The DHS used handheld devices for many questionnaires to reduce transcription error 
and to collect GPS points for cluster locations (Cutts et al., 2016; DHS, 2013; Ministry of 
Planning and Implementation of the Modern Revolution et al., 2014). 
Given the history, the rigor in the survey sampling process, the degree of 
standardization, and the quality control the DHS has been cited as one of the best data 
sources to use to compare health indicators and immunization data from middle- and low-
income countries (Cutts et al., 2013; Murray et al., 2003). This provides support for the 
survey design and the potential to reproduce the nested serosurvey because the results 
will provide concise data for programmatic change required by the Ministry of Health 
and the development partners. This is important because this is the first DHS in Africa to 
include biomarkers for vaccine preventable diseases for adults and children nationwide.  
 The study is generalizable to the DRC with the exceptions of the limitations that 
have been previously mentioned and the mobile and remote subpopulations that were not 
included in the study population. To avoid threats to construct validity precise definitions 
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and measure of variables were included in the study design. Threats to statistical 
conclusions can occur because a study either did not have the appropriate statistical 
power or violated statistical assumptions regarding the data because of poor statistical 
power (Creswell, 2009). The appropriate statistical analyses were conducted to test the 
hypotheses that are put forward in this proposal prior to the onset of the study and the 
statistical power was evaluated once the study sample was finalized. 
Ethical Procedures 
The DRC DHS and the nested serosurvey for tetanus antibodies were approved by 
the DRC Ethical Review Board in 2012. All participants were given an explanation of the 
reasons for the survey, the ways the collected data would be used and disseminated, and 
the reasons why blood specimens were being collected. This information was fully 
disclosed and interviewers obtained consent from the participants. Rules for data 
confidentiality and data integrity were applied to the DHS. The data are de-identified, and 
geospatial data points (GPS) are kept in a separate file. Linkages can be made between 
DHS data and serology through a unique barcode assigned to each individual. For the 
DHS, ICF International has reviewed ethical concerns associated with the survey, and a 
plan to address them is included in the handbook for the DHS (DHS, 2013). As required 
by the Walden Internal Review Board, I completed the course on Human Research 
Protections Training offered by the National Institutes of Health Office of Extramural 
Research. All DRC DHS data were kept confidential. All data were stored on a password- 
protected computer located in a locked office when not in use. All pertinent information 
generated from the study was shared with the DRC Ministry of Health for programmatic 
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decision-making. All initial analyses will be reviewed with the Ministry prior to any 
presentation in an international conference or publication.  
Summary 
In chapter three I provided a detailed review of the research methods for this 
quantitative, observational cross-sectional study using secondary data. The nationally 
representative stratified sample has an advantage because it allows DRC Ministry of 
Health to review key demographic and health indicators and trends. In addition, the 
nested serosurvey for immunity against tetanus allows for analysis and generalization at 
the national and provincial levels. The first DHS was conducted in the DRC in 2007, 
though without a nested serosurvey.  
This research used archival data from the 2013–2014 DRC DHS and anonymized 
laboratory results from the serosurvey nested within the DHS. Following the precise and 
standardized data cleaning procedures, the appropriate univariate and bivariate analyses 
were conducted to identify the independent variables potentially related to immunity 
against tetanus by their statistical significance. These were followed by tests of 
collinearity to inform the inclusion of independent variables in the multivariate analysis. 
Potentially significant threats to internal and external validity have been addressed by 
DHS investigators in their methodology. All procedures to assure ethical assurances and 
considerations have been addressed through DHS procedures.  
 The study had a sufficient sample size, with results from 8,120 sero samples with 
corresponding survey data included in the study. The study sample was determined 
sufficient for generalization with the provincial sample size ranging from 201 to 701 per 
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province with statistical power of 0.9122 calculated for the minimum provincial sample 
size of 201. Therefore, the final analysis was done for the 26 new provinces to allow for 
programmatic use by the Ministry of Health.  
 The data were requested from both the DHS and from UCLA following the 
receipt of Walden IRB approval. The Walden IRB approval number for this study was 
01-15-19-07769. The data analysis plan included univariate analysis, bivariate analysis 
using Rao-Scott chi-square test, and multiple logistic regression using a complex sample 
model to account for the study design. Variables with the strongest associations were 
retained in the model.  
Threats to validity of this study were assessed and proper steps were taken to 
ensure appropriate statistical power to avoid statistical conclusion validity which may be 
the largest threat. Threats to external validity were acknowledged. Although findings 
from the DRC DHS may not be generalizable to all countries, there will be components 
that are comparable to other countries in the region due to immunization practice.  
To summarize, Chapter 3 described the research methodology that was used to 




Chapter 4: Results 
This chapter provides the results of the observational cross-sectional study using 
data from the 2013–2014 DHS, coupled with the results from a nested serosurvey to 
assess the protective immunity against tetanus among the adult population in DRC. The 
research questions examined the association between protective immunity against tetanus 
and independent variables of age, sex, province, place of residence (urban, rural), and 
women reporting to have at least one visit to a provider of antenatal care services in the 
past 5 years. Other important factors, such as education, occupation, ethnicity, religion, 
literacy, and health insurance, were also explored. This chapter provides an overview of 
the demographic and socioeconomic characteristics of the study sample, reviews the 
research questions and hypotheses, reports the statistical analyses, and summarizes the 
findings. 
Characteristics of the Sample 
In total, 8,120 adults were included in the unweighted sample. Due to the complex 
sampling of the survey, the sample was weighted as described in the methodology, and 
these weights were used for all analyses, figures, and tables. The weighted sample size 
for this study was 8,169. 
Demographic Characteristics and Results of Bivariate Analysis 
This study included women from 15 to 49 years of age, reflecting women of 
childbearing age, and men from 15 to 59 years. In this study, 40% of the population were 
15–24 years of age, and a third were between ages 25 and 34. Overall, 53% of the study 
population was women and comprised 58% of 20–24-year-olds, 61% of 25–29-year-olds, 
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and 57% of 35–39-year-olds. Women had a mean age of 28.4 years ± a standard 
deviation of 9.5 years, compared to men, who had a mean age of 31.6 years ± a standard 
deviation of 12.2 years.  
DRC is a predominately rural country. Therefore 64% of the sample was drawn 
from rural areas and only 36% from urban areas. Every province had participants from 
both rural and urban areas except for Kinshasa, which is the only all-urban province (see 
Figure 1). The 14 major ethnicities of DRC were represented (see Table 2 and Figure 3), 
with Kasai, Katanga, and Tanganyika ethnicities making up 26% of the study population; 
followed by 19% for Basele-K, Man, and Kivu ethnicities from North and South Kivu 
and Maniema; and 17% for Bas-Kasai and Kwilu-Kwango ethnicities primarily found in 
Kwilu province. Kinshasa province had the most diverse number of ethnic groups.  
 

























Bakango Nord and Sud Bas-Kasai and Kwilu-Kwngo Cuvette Central
Ugangi and Itimbiri Uele Lac Albert Basele-K, Man and Kivu
Kasai, Katanga, Tanganika Lunda, Pygmy and others
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Among all participants, 11% had no formal education, 31% completed primary 
school, 53% completed some or all secondary education, and 5% had gone on for further 
studies. Overall 40% of men and women of the study population continued to secondary 
school, while 16% of women and 4% of men did not have a formal education (see Figure 
4). Most adolescents in this study, both boys and girls, attended at least some primary 
school.  
 
Figure 4. Education in DRC, 2013–2014. 
In this study, 76% of participants were working; and of those working, 43% 
worked in agriculture where a majority were self-employed, 15% worked in sales or 
clerical positions, and 6% held professional or managerial positions (Appendix A, Table 
A1). Of the working study population, 64% were women who made up 53% of the 
agriculture workers, while men made up 92% of the laborer work force and 80% of 






















Regarding wealth, close to one third of the participants were in the poorest or 
poor categories of the wealth index, 22% in the richest category, and the remaining 39% 
in the middle and high wealth categories. The wealth index represented family wealth, 
documenting assets such as housing type, access to safe water supply, and transportation 
and was not reflective of individual wealth. Regarding marital status, 62% were married 
or living with their partner, whereas 31% were never married, and 7% were widowed, 
divorced, or separated. Predominant religions included Catholic (29%), Protestant (28%) 
and other Christian religions (36%), while Islam and local religions accounted for 6% and 
a small minority had no faith. 
In the 4 months prior to the DHS, 16% of women and 14% of men went to a 
health facility for medical treatment. The primary reason was malaria or fever; however, 
5% of men went to a health facility because of an injury (Ministry of Planning and 
Implementation of the Modern Revolution et al., 2014). Health insurance was limited in 
DRC; only 4% of respondents had health insurance (Appendix A, Table A1). Of the 
4,349 women in this study, 25% never had children, 25% had one to two children, 20% 
had three to four, and 30% had over five. Of the women who had been pregnant, the 
range of age at first birth was 10 years to 42 years.  
Of the 2,581 women in this study who were currently pregnant or had a 
pregnancy within the past 5 years, 87% had been seen by a provider of antenatal care at 
least once. By age group, 94% of those 15–19 years old and 91% of 20–24-year-olds 
made at least one antenatal visit (Appendix A, Table A2). These percentages were much 
lower in women who were pregnant in older age groups, where only 79% of those 40–44 
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and 77% of those 45–49 years of age made a visit during their pregnancy. This disparity 
in antenatal visits by age was probably responsible at least in part for the finding that only 
57% of women 40–49 compared to 74% of those 15 to 39 received at least one dose of 
TTCV (see Figure 5).  
Vaccination data were self-reported with no documentation submitted for 
verification. Without documentation and a review of the immunization record, the verity 
of the self-report cannot be ascertained. However, in this study the blood samples were 
collected and tested to serve as a proxy and provide evidence of tetanus vaccination and 
seroprotection among women (Appendix A, Table A2). 
 
Figure 5. Women attending antenatal clinic with receipt of TTCV by age, 2013–2014. 
Many variables in the bivariate analysis had a significant association with 



























Did not receive 1-2 TTCV 3 or more TTCV Don't know
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Table A1), including sex, age, province, urban/rural, education, ethnicity, occupation, 
literacy, marital status, and religion. Several variables were not included in the final 
model including literacy due to collinearity and marital status because it was not 
significant for men p = 0.638 or women p = 0.236 (see Appendix A, Tables A2 and A3). 
Wealth index (p = 0.715) and health insurance (p = 0.938) were not found to be 
associated with protective immunity against tetanus and were also not included in the 
model (see Appendix A, Table A1). The variables included in the final model were sex, 
age, province, urban/rural, education, ethnicity, occupation, and religion. 
Research Questions and Hypotheses Testing 
To answer the four research questions, each hypothesis was tested to assess 
potential associations between the independent variable and dependent variables. For 
each of the hypotheses, Rao-Scott chi square and complex sample multiple logistic 
regression models were used while controlling for covariates. 
RQ1: Is there an association between age and protective immunity against tetanus 
among adults in DRC?  
H01: There is no association between age and protective immunity against tetanus 
among adults in DRC.  
Ha1: There is an association between age and protective immunity against tetanus 
among adults in DRC. 
The results showed that age was significantly associated with protective immunity 
(χ² = 485.6 with p = 0.001). The odds of protection among the 20–24-year-olds was over 
twice as high (OR 2.43), while the odds of protection in the 25–34-year-old group was 
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three and a half times as high (OR 3.54), as in those aged 15–19, and the odds of 
protection showed a decrease in those aged 35 and older (see Table 4). The covariates 
sex, province, religion, occupation, and education were entered into the model. Age 
remained significant in the multivariate model (p = 0.001). A similar result was observed 
in the adjusted analyses for 20–25-year-olds (AOR 2.94, 95% CI 2.29 – 3.77). However, 
the odds of protection among the age group 30–34 was much higher (AOR 5.24, 95% CI 
3.92 - 7.00). The odds of protection then declined with increasing age as it did in the 
unadjusted analyses, with the exception being men 50–59 (AOR 2.85, 95% CI 1.88 – 
4.31). Therefore, I rejected the null hypothesis that stated there is no association between 
age and protective immunity against tetanus among adults in DRC.  
Table 4 
 
Bivariate and Multivariate Regression Model for Association of Protective Immunity 
Against Tetanus and Age  
Independent Variables                   
 χ² p UOR 95% CI Wald p AOR 95% CI 
Characteristics        LL UL       LL UL 
Age (years)           
15-19 485.6 0.05 1   39.6 0.001 1   
20-24   2.43* 1.99 2.97 
  
2.94* 2.29 3.77 
25-29   3.54* 2.84 4.41 
  
4.40* 3.34 5.81 
30-34   3.54* 2.77 4.54 
  
5.24* 3.92 7.00 
35-39   2.92* 2.31 3.68 
  
3.69* 2.72 5.02 
40-44   2.05* 1.65 2.55 
  
2.77* 2.15 3.57 
45-49   1.96* 1.53 2.52 
  
2.53* 1.88 3.39 
50-59     0.57 0.39 0.81     2.85* 1.88 4.31 
Note. * p < 0.05 bold is considered significant in model. Variables adjusted for in the 
model: sex, province, education, occupation, religion. 50-59 age group is only men. UOR 
is the unadjusted odds ratio, LL is the lower limit and UL is the upper limit of the 95% 




RQ2: Is there an association between sex and protective immunity against tetanus 
among adults in DRC?  
H02: There is no association between sex and protective immunity against tetanus 
among adults in DRC.  
Ha2: There is an association between sex and protective immunity against tetanus 
among adults in DRC.  
Sex was the most significant predictor of protective immunity (χ² = 1917.86, p = 
0.001). In the bivariate model, the odds of women being protected against tetanus were 
nine times as high as in men (OR = 9.10, 95% CI 7.86–10.53). All significant covariates 
from the bivariate analysis (sex, age, province, education, religion, and occupation) were 
entered into the multivariate model, and after controlling for them, sex and nothing else 
remained significant (p = 0.001) with an AOR 10.46 (95% CI 8.88-12.33; see Table 5).  
Table 5 
 
Bivariate and Multivariate Logistic Regression Models for Association of Protective 
Immunity and Sex  
Independent Variables                   
  χ² p UOR 95% CI Wald p AOR 95% CI 
Characteristics        LL UL       LL UL 
Sex           
Men 1919 0.1 1   794 0 1   
Women     9.10* 7.86 10.53     10.46* 8.88 12.33 
Note. * p < 0.05 bold is considered significant in the model. Variables adjusted in the 
model: age, province, education, occupation, religion.  
 
As shown in Figure 6 the percentage of women protected, compared to men of the 
same age, was higher in every age category with the adjusted odds of women being more 




Figure 6. Men and women by age with protective immunity against tetanus in the DRC 
2013–2014. 
After controlling for confounders, the strongest predictor for protective immunity 
against tetanus was a woman. Therefore, I rejected the H02 null hypothesis that stated 
there is no association between sex and protective immunity against tetanus.  
RQ3: Is there an association between province and place of residence 
(urban/rural) and protective immunity against tetanus among adults in DRC? 
H03 – There is no association between province and place of residence 
(urban/rural) and protective immunity against tetanus among adults in the DRC. 
Ha3 – There is an association between province and place of residence (urban/ 
rural) and protective immunity against tetanus among adults in the DRC.  
In the initial bivariate analysis, urban/rural area of residence was not found to be 
significant (χ² = 0.3, p = 0.676 ; see Appendix A, Table A1). In stratified analyses by sex, 


















15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-59
78 
 
women (χ² = 9.3, p = 0.002, see Appendix A, Table A2) but not for men (χ² = 0.64, p = 
0.424, see Appendix A, Table A3).  
For men, the odds of men being protected were slightly higher, but not significant, 
in an urban environment (AOR 1.1, 95% CI 0.87-1.40 ; see Appendix A, Table A2) than 
in rural areas. The odds of women being protected were 1.5 times as high in an urban 
area than in a rural environment (see Appendix A, Table A3 ; AOR 1.50, 95% CI 1.18-
2.14).  
Province was found to be significantly associated with protective immunity (χ² = 
74.7, p = 0.007) after adjusting for age, sex, occupation, and religion (Table 6). In Kwilu 
and Equateur provinces, the odds of protection for adults were one and a half times as 
high as in Kinshasa (AOR 1.57, 95%, CI 1.1-2.25) and (AOR 1.67, 95% CI 1.12-2.51). In 
Tanganika the odds of protective immunity against tetanus were slightly more than half 
that of Kinshasa (AOR 0.58, 95% CI 0.43-0.78) making living in Tanganyika a potential 
risk factor for lack of protective immunity. Therefore, I rejected the null hypotheses H03 
that stated there is no association between province and protective immunity against 
tetanus among adults in DRC, while I did not reject the null hypotheses that stated there 
is no association between place of residence (urban/rural) and protective immunity 






Bivariate and Multivariate Logistic Regression Results for the Association of Protective 
Immunity and Province  
Independent 
Variables  
χ² p UOR 95% CI Wald p AOR 95% CI 
Characteristics        LL UL       LL UL 
Province  
          
Kinshasa 74.5 0.05 1 
  




1.19 0.94 1.51 
  
1.34 0.96 1.87 
Kwilu 
  
1.49* 1.13 1.96 
  
1.67* 1.12 2.51 
Mai-Ndombe 
  
0.98 0.70 1.38 
  
1.04 0.65 1.68 
Konho-Central 
  
1.07 0.83 1.37 
  
1.14 0.83 1.57 
Equateur 
  
1.17 0.94 1.46 
  
1.57* 1.10 2.25 
Mongala 
  
1.17 0.84 1.62 
  
1.30 0.89 1.89 
Nord-Ubangi 
  
1.36* 1.01 1.82 
  
1.57* 1.09 2.27 
Sud-Ubangi 
  
1.21 0.82 1.79 
  
1.42 0.83 2.41 
Tshuapa 
  
0.77 0.57 1.04 
  
0.74 0.46 1.19 
Kasai 
  
0.64 0.35 1.16 
  
0.61 0.31 1.19 
Kasai-Central 
  
1.17 0.82 1.68 
  
1.34 0.80 2.23 
Kasai-Oriental 
  
1.19 0.98 1.44 
  
1.42* 1.05 1.92 
Lomami 
  
1.07 0.89 1.28 
  
1.19 0.94 1.51 
Sankuru 
  
0.74 0.44 1.25 
  
0.66 0.32 1.36 
Haute-Katanga 
  
1.00 0.71 1.42 
  
1.07 0.64 1.78 
Haute-Lomami 
  
0.97 0.72 1.30 
  
1.11 0.72 1.72 
Lualaba 
  
1.22 0.93 1.61 
  
1.41* 1.01 1.98 
Tanganika 
  
0.58 0.43 0.78 
  
0.48 0.34 0.70 
Maniema 
  
0.95 0.70 1.28 
  
0.94 0.62 1.43 
Nord-Kivu 
  
0.84 0.62 1.13 
  
0.81 0.54 1.22 
Bas-Uele 
  
1.19 0.80 1.77 
  
1.39 0.94 2.06 
Haute-Uele 
  
1.09 0.82 1.44 
  
1.18 0.81 1.74 
Ituri 
  
1.03 0.68 1.58 
  
1.15 0.65 2.02 
Tshopo 
  
0.77 0.48 1.22 
  
0.76 0.42 1.38 
Sud-Kivu     0.98 0.72 1.33     0.97 0.67 1.40 
Note. * p < 0.05 bold is considered significant in the model. Variables adjusted for in the 





RQ4: Is there an association between antenatal care and protective immunity 
against tetanus among adult women in the DRC? 
H04 - There is no association between antenatal care and protective immunity 
against tetanus among adult women in the DRC. 
Ha4 - There is an association between antenatal care and protective immunity 
against tetanus among adult women in the DRC.  
Only women who reported a live birth within the past five years were asked if 
they had made a visit to a provider of antenatal care. There was a statistically significant 
association in the unadjusted analysis between antenatal care and protective immunity 
against tetanus among women in the DRC, (χ² = 18.35, p = 0.001). Women receiving 
antenatal care had twice the odds of protective immunity as those that did not receive 
antenatal care (OR 2.15, 95% CI 1.51-3.05). 
Figure 7 shows the proportion of men, nulliparous and parous women in each 
five-year birth cohort with protective immunity. While all individuals born between 1984 
and 1999 had the opportunity for childhood immunization, it is unlikely there was an 
opportunity for a booster dose until women were of childbearing age and pregnant or 
until either men or women were injured. The percentage of men that were protected 
rarely exceeded 20%, while among nulliparous women, the percentage was high in the 
early birth cohorts but fell dramatically with later birth cohorts. These results in teenage 
men and nulliparous women reflected missed opportunities for immunization and waning 




Figure 7. Protective immunity against tetanus in men, nulliparous and parous women by 
year of birth in 5-year increments in DRC 2013–2014.  
In the multivariate model shown in Table 7 receiving antenatal care remained 
significantly associated with protective immunity (AOR 2.18, 95% CI 1.53 - 3.09) after 
adjusting for covariates age, province, urban/rural, education, ethnicity, wealth, and 
number of TTCV before the last birth. Those who received antenatal care were a little 
more than twice as likely to have protective immunity than those that did not report such 
care. Therefore, I rejected the null hypotheses H04 stating there is no association between 
antenatal care and the level of protective immunity against tetanus among adult women in 
























Bivariate and Multivariate Logistic Regression Results for the Association of Protective 
Immunity and Women 
Independent 
Variables  χ² p UOR 95% CI Wald p AOR 95% CI 
Prenatal visit to 
any provider       LL UL       LL UL 
No  18.35 0.05 1   20.8 0 1   
Yes     2.15* 1.51 3.05     2.18* 1.53 3.09 
Note. * p < 0.05 bold is considered significant in the model. Cox and Snell R² = 0.27. 
Variables adjusted for in the model: age, province, urban/rural, education, prenatal care, 
ethnicity, wealth, # TTCV before last birth 
 
The final multiple regression model for men and women identified sex, age and 
province as the three factors that were associated with protective immunity against 
tetanus (Table 8). The three independent variables, sex, age, and province, together 







Multiple Regression Model of Factors Associated with Protective Immunity Total Sample 
Independent  
Variables 
SE Wald p AOR 95% CI 






Women 0.083 794.1 
 
10.46* 8.88 12.33 
Age (years) 
      
15-19 
 




2.94* 2.29 3.77 
25-29 0.14 
  
4.40* 3.34 5.81 
30-34 0.15 
  
5.24* 3.92 7 
35-39 0.16 
  
3.69* 2.72 5.02 
40-44 0.13 
  
2.77* 2.15 3.57 
45-49 0.15 
  
2.53* 1.88 3.39 
50-59 0.21 
  
2.85* 1.88 4.31 
Province  
      
Kinshasa 
 




1.34 0.96 1.87 
Kwilu 0.21 
  
1.67* 1.12 2.51 
Mai-Ndombe 0.24 
  
1.04 0.65 1.68 
Konho-Central 0.16 
  
1.14 0.83 1.57 
Equateur 0.18 
  
1.57* 1.1 2.25 
Mongala 0.19 
  
1.3 0.89 1.89 
Nord-Ubangi 0.19 
  
1.57* 1.09 2.27 
Sud-Ubangi 0.27 
  
1.42 0.83 2.41 
Tshuapa 0.24 
  
0.74 0.46 1.19 
Kasai 0.34 
  
0.61 0.31 1.19 
Kasai-Central 0.26 
  
1.34 0.8 2.23 
Kasai-Oriental 0.15 
  
1.42* 1.05 1.92 
Lomami 0.12 
  
1.19 0.94 1.51 
Sankuru 0.37 
  
0.66 0.32 1.36 
Haute-Katanga 0.26 
  
1.07 0.64 1.78 
Haute-Lomami 0.22 
  
1.11 0.72 1.72 
Lualaba 0.17 
  
1.41* 1.01 1.98 
Tanganika 0.19 
  
0.48 0.34 0.7 
Maniema 0.21 
  
0.94 0.62 1.43 
Nord-Kivu 0.21 
  
0.81 0.54 1.22 
Bas-Uele 0.2 
  
1.39 0.94 2.06 
Haute-Uele 0.2 
  
1.18 0.81 1.74 
Ituri 0.29 
  
1.15 0.65 2.02 
Tshopo 0.3 
  
0.76 0.42 1.38 
Sud-Kivu 0.19     0.97 0.67 1.4 
Note. * p < 0.05 bold is considered significant. Cox and Snell R² = 0.26. Variables 
adjusted for in the model: age, sex, province, education, occupation, religion. SE refers to 
standard error.   
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In summary, the final multiple regression model for women identified two factors, 
age and prenatal visits, that were associated with protective immunity against tetanus 
(Table 9). The six independent variables, age, province, education, occupation, religion, 
and prenatal visit to any provider, together account for 26% of the explanation of why 
women pregnant within the past five years had protective immunity against tetanus.  
Table 9 
 
Multiple Regression Model of Factors Associated with Protective Immunity for Women  
Independent 
Variables  SE Wald p AOR 95% CI 
Characteristics          LL UL 
Age (years)       
15-19  20.94 0.002 1   
20-24 0.25   1.40 0.86 2.27 
25-29 0.24   1.79* 1.11 2.90 
30-34 0.29   2.86* 1.62 5.05 
35-39 0.29   1.57 0.89 2.75 
40-44 0.28   1.14 0.65 1.99 
45-49 0.46   1.66 0.67 4.12 
Prenatal visit to any provider       
No  18.89 0.000 1   
Yes 0.18     2.18* 1.53 3.09 
Note. * p < 0.05 bold is considered significant. Variables adjusted for in the model: age, 
province, education, occupation, religion, prenatal visit to any provider.  
 
Summary and Transition  
The study findings were presented in this chapter. These included a summary of 
demographic, socioeconomic, and other characteristics of the study population. The 
statistical analyses that were conducted to answer the research questions were reviewed, 
and each of the four research questions was assessed to determine the variables 
significantly associated with immunity against tetanus in adults in the DRC. The 
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variables age, sex, and province were found to be significant in the all subjects model, 
while age and antenatal care were found to be significant in the women’s model. 
Sex was the most significant finding as women were more than 10 times as likely 
to have protective immunity against tetanus as men with an AOR of 10.46. Age was 
significant in the multivariate model, as 30–34-year-olds were more than 5 times as likely 
to be protected (AOR 5.24) as those 15 to 19 years of age. Province was also significant 
with multiple provinces having about half the protective immunity than Kinshasa. 
Finally, women that attended antenatal clinics were twice as likely to be protected against 
tetanus as pregnant women that did not attend them. Chapter 5 provides a discussion of 
the findings, the limitations of the study, recommendations for future research and action, 




Chapter 5: Summary, Conclusion, and Recommendations 
Summary of the Study 
This study had two major purposes. The first was to demonstrate that a serosurvey 
could be used to assess protective immunity against tetanus among adult populations in 
DRC. The second purpose was to identify the characteristics of populations at greatest 
risk of tetanus infection based on lowered immunity levels. In this chapter, I describe the 
results of the study to demonstrate that the purpose was achieved. Social change should 
occur because of the scientific evidence provided by the study findings adding to the 
body of evidence from the findings of serosurveys and immunity against tetanus in adults 
in DRC and in Africa. Chapter 5 includes a discussion of the study findings, 
recommendations for further research, ideas for social change, recommendations for 
action, and the conclusion to this study.  
Discussion and Interpretation of Findings  
One of the most significant findings from this study was the association between 
protective immunity and sex. The likelihood of women having protective immunity 
against tetanus was 10 times higher than in men. Overall, 65% of women and 17% of 
men were protected. These findings were similar to those of other studies in sub-Saharan 
Africa, including in Kenya where 96% of women were seroprotected compared to 45% of 
men; in Tanzania, where 94% of women were protected compared to 28% of men; and in 
Mozambique, where 90% of women and 64% of men were protected (Scobie et al., 
2017). Women may receive TTCV at prenatal care visits and during MNTE campaigns 
while men may only be immunized as infants or if injured, and in the case of 
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Mozambique, in school. Immunization programs in most African countries were initially 
designed to provide vaccination during the first year of life and for women during 
pregnancy. Except Mozambique, few African countries provided immunization after the 
age of 1 year, adolescent or school-based vaccination, or catch-up immunization for those 
who were not fully immunized (Dalal et al., 2016; Mihigo et al., 2017). 
In a recent DHS study on childhood immunization in DRC, Acharya Kismul, 
Mapatano, and Hatløy (2018) found that 4 of 5 children in DRC were from households 
headed by a man. When looking at risk factors, there are professions that result in more 
exposure to tetanus for men and women, including agriculture, manual labor, and military 
(Roper et al., 2017). In the current study in DRC, 59% of men and 14% of women were 
named as heads of their respective households. Of the female heads of households, 73% 
were protected against tetanus; only 13% of men in men-led households were. Being 
unprotected puts families at risk. This lack of protection against tetanus in men was also 
shown in a serosurvey in Uganda (Makumbi et al., 2019). Makumbi found 43% of men 
and boys between 10–49 years of age were unprotected against tetanus. In the Uganda 
study, participants were given two doses of TTCV 28 days apart, and 100% of the study 
population was protected against tetanus at the 42-day assessment. Tetanus mortality is 
high for those unprotected, as demonstrated by a retrospective record review conducted 
in Lubumbashi hospital in Haute Katanga Province, DRC (Muteya et al., 2013). Of the 
patients admitted to the intensive care unit with tetanus, 95% were men 30–50 years old, 
and 52% died from tetanus while in the hospital. The lower level of protection against 
tetanus in men was also highlighted by 13 cases of tetanus in men resulting in nine deaths 
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in six countries over a period of 6 years (CDC, 2016; Dalal et al., 2016). These deaths 
followed voluntary male circumcision procedures, and the subsequent investigations led 
to a change in WHO immunization policy that men should now be evaluated and 
vaccinated against tetanus prior to circumcision procedures (WHO, 2017).  
The results in this study demonstrated an association between age and protective 
immunity with the odds of protection peaking at 2.5 to 3.5 times in those aged 20 to 35 
compared to 15–19-year-olds. This age variation was largely driven by the increase in 
protective immunity in women. In a serosurvey in Laos to evaluate heath care workers’ 
immunity to vaccine-preventable diseases, 90% of women versus 38% of men were 
protected against tetanus (Black et al., 2015). In Laos, like DRC, TTCV was not 
introduced until the late 1970s, so adults 34 or older were unlikely to be immunized 
against tetanus unless they received antenatal care or were injured. In Cambodia, Scobie 
et al. (2016) found that 63% of women aged 15–19 had protective immunity against 
tetanus, as compared to 87% of 20–24-year-olds. These percentages were much higher 
than those of this study; I found that 35% of women aged 15–19 were protected, 
compared to 65% of 20–24-year-olds in DRC. In contrast, among men in the DRC, only 
15% of those 15–19 years of age and 20% of those 20–24 were protected against tetanus. 
As DRC has no school booster program, the current level of immunity could have been 
due to TTCV following an injury or vaccination for employment. The decline in 
immunity in adults with increasing age that was seen in this study was not surprising 
because adults born before the EPI program became well established may never have had 
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the opportunity to receive TTCV. Waning immunity with increasing age has also been 
documented in other studies of adults (Aboud et al., 2002; Roper et al., 2017).  
The findings from this study demonstrated differences in protection against 
tetanus in the population across the provinces when compared with Kinshasa. Areas of 
low protective immunity in some provinces were also areas known for armed conflict, 
including Equator, North Kivu, and Tanganika (Grundy & Biggs, 2019). 
Attending an antenatal care clinic was found to be associated with protection 
against tetanus. Women attending antenatal care were twice as likely to be protected 
against tetanus. These findings support the effectiveness of booster doses in pregnancy, 
which was also shown in a recent study in Cambodia (Scobie et al., 2016). The 
researchers found that in women who had received at least one dose of TTCV during 
their last pregnancy, as doses of TTCV increased, protection also increased, with 98% of 
women with two or more doses being protected. I found in the current study, of women 
that were currently pregnant or had given birth in the last five years, 81% of women 
reporting 1-2 doses of TTCV and 87% of women with 3-4 doses were protected against 
tetanus. Similar to this study, Cambodia women 15–19 years of age were the most likely 
to be unprotected against tetanus, and this was attributed to missing TTCV campaign 
doses and, if pregnant, the first booster.  
In a study using DHS data in Kenya researchers reviewed antenatal visits and 
receipt of TTCV of women that had been pregnant within 12 months of the survey (Haile, 
Chertok, & Teweldeberhan, 2012). They found that 90% of pregnant women attended at 
least one antenatal clinic, and they estimated based on self-reports that 69% of the 
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women that had been pregnant in the past year had enough vaccinations to provide 
protection against tetanus at the birth of their child, although no serologic tests were 
conducted. In this study, among women who gave birth in the 12 months prior to the 
DRC DHS, 80% had serologic evidence of protection against tetanus.  
Support for the Theoretical Framework  
The results of this work indicate that a majority of women are immunized against 
tetanus, and that the presence of antibodies against tetanus provides immunological 
evidence of preventive action taken by the individual. For women of childbearing age and 
especially pregnant women, this evidence is important because antibodies against tetanus 
can only be acquired through vaccination. Preventive action occurs when a person acts 
from the following perceptions: (a)susceptibility to acquiring the disease, (b)severity of 
illness if acquired, (c)perceived personal benefits, (d)perceived barriers or negative 
aspects of action, (e)cues that may trigger action, and (f) a conviction that the individual 
can change behavior to achieve the desired outcome. HBM continues to be widely used 
to support public health intervention programs such as immunization and antenatal care 
(Glanz & Bishop, 2010). This model frames the key issues to address related to health-
seeking behavior. HBM suggests that if the risk of the disease is known, then an 
individual will make the choice to prevent the disease if health-related interventions, such 
as immunization are made available to them and findings of high levels of protective 




This study has shown evidence of health-seeking behavior resulting in protective 
immunity against tetanus. The study results provide evidence of protection against 
tetanus that can only be achieved through immunization. The current DHS data provide 
evidence of health-seeking behavior of men and women. Given this information, the 
DRC should avail adults the opportunity for booster immunization against tetanus for 
men and women. 
Limitations 
This study had limitations in that I used secondary data from the DHS in which 
the variables were operationalized for the primary study and were not developed 
specifically for this study.  
Another limitation was that the responses to the DHS questions related to 
antenatal care and to receiving tetanus vaccination were based on recall (Cutts et al., 
2016). In addition, the DHS was only administered to those living in a house; adults 
living on military bases and in hotels, as well as homeless adults, were not included in 
this survey (DHS, 2013). Furthermore, mobile and other difficult to reach populations 
and people living in active conflict zones may not have been represented.  
Although great care was taken to split original survey sample matched pairs 
evenly between the polio and tetanus serosurveys by province, cluster, sex, and age-
strata, there is a probability the samples may have differed due to singletons of men or 
women. Finally, because men were not asked about immunization, there could not have 
been any comparison made between sex and vaccination history by recall or record 
(Corsi, Neuman, Finlay, & Subramanian, 2012).  
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Recommendations for Future Research  
From this study there are several areas that would be appropriate for future 
research. The use of periodic serosurveys to support MNTE goals should be further 
evaluated as well as the extent that campaigns for women 15–49 years of age are 
effective in improving immunity in poorly performing areas (Eshetu et al., 2018). 
Further, the current study provided evidence of waning immunity and lack of immunity 
in adolescents. In contrast, data from Mozambique revealed that school-based programs 
had a substantial impact on boosting immunity in adolescents (Scobie et al., 2017). 
Therefore, operational research and innovative actions by the MOH partnering with the 
education department are recommended to reach primary school children in DRC for 
booster vaccination, as the current study found that a majority of children attended some 
primary school.  
As the current study showed evidence of low immunity in men and adolescents 
and evidence of health-seeking behavior in the population in DRC, operational research 
should also be conducted within the health facilities to study the inclusion of TTCV for 
adults. Finally, the MOH in DRC should examine the feasibility of providing vaccination 
services within the outpatient setting and seek opportunities to educate clinicians to 
increase their knowledge, as was done by research in Turkey (Egici, Taş, Özkarafakılı, & 
Öztürk, 2018).  
Recommendations for Action 
Perhaps the most important recommendation for DRC would be to consider full 
implementation of the WHO recommendations for tetanus immunization (WHO, 2018). 
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This implementation would provide booster doses for all children over the age of 1 year 
and require school age immunization. To implement the WHO recommendations, the 
MOH in the DRC, together with supportive partners, would need to review the total cost 
needs for operations and vaccines, and the feasibility of implementing the 
recommendations for children over 9 months, school age children, and adults. This 
implementation should show a clear value as the cost to protect an individual against 
tetanus is estimated to be less than $1 for the vaccine and supplies (Burgess et al., 2017). 
These WHO recommendations should be reviewed within the context of the health 
systems that support the immunization program in the development of the overall plan 
(Kamadjeu, 2017). Serosurveys should be used to evaluate the immunity levels of 
children under 5, children 5–15-years of age and adults on a periodic basis.  
Implications for Social Change 
There have been several examples of outcomes of a DHS making contributions to 
health policy making (Nolan, Lucas, Choi, Fabic, & Adetunji, 2017). The current study 
provides scientific evidence for positive social change as the quantitative data showed 
gaps in protective immunity against tetanus and provided information on inequity in 
preventive immunization against tetanus by sex. Women were 10 times as likely to be 
protected against tetanus, and overall 17% of the men in the study had evidence of 
protective immunity. This study also showed the gap by age, specifically in young adults 
and provided evidence that both sexes have lower immunity as teens until women are 
targeted for MNTE services. These data can inform and shape immunization policy, 
support requests to government and donors for public health financing for immunization, 
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and focus health education efforts on the susceptible populations. Finally, this study 
provided data which the immunization program requires in assessing progress of MNTE, 
because using serology can be incorporated in MNTE assessments in the DRC and other 
countries. 
Conclusions 
There are many people who have spent their lifetimes working to close the 
immunity gap in maternal, neonatal and non-neonatal tetanus. The current study provides 
evidence of the efforts that the DRC has put into MNTE, but there is a gap in services 
provided to children over the age of 1 year through the age of 15 and then for men of all 
ages. As Burgess and Gasse emphasized, all individuals need to be protected against 
tetanus and for that they must be immunized (Burgess et al., 2017). The current study has 
identified the inequity in immunization services for adolescents and adults, specifically 
men and nonchildbearing women, and with this evidence it will hopefully provide the 
impetus for immunization policy to be addressed.  
In 1986, on the steps of a clinic in Liberia, I watched as a child died in the arms of 
her mother from neonatal tetanus implanting an image that would remain with me for 
years. Whether in Liberia or the DRC, whether a neonate, adolescent, or adult¬, whether 
male or female, surely now with years of research, a safe, inexpensive effective vaccine, 
global guidance documents that support protection against tetanus across the lifespan and 
the quantitative evidence on limits of protective immunity against tetanus in the DRC, the 
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Appendix A: Descriptive Analysis & Bivariate Regression Models 
Table A1 
 
Descriptive Analysis & Bivariate Regression Model, Adults  
 
Independent Variables  Weighted                       
 Adults  Unprotected  Protected         
Characteristics  n % n  % n % χ² df p-value UOR LL UL  
             
Sex             
Men 3820 46.8 3161 82.7 659 17.3 1918.7 1 0.000 1   
Women 4349 53.2 1502 34.5 2847 65.5   
 
9.10 7.86 10.53 




   




   
15-19 1698 20.8 1258 74.1 440 25.9 485.6 7 0.000 1   




2.43 1.99 2.97 




3.54 2.84 4.41 




3.54 2.77 4.54 




2.92 2.31 3.68 




2.05 1.65 2.55 




1.96 1.53 2.52 













   




   
Kinshasa 875 10.7 506 57.8 369 42.2 74.7 25 0.007 1   




1.19 0.94 1.51 




1.49 1.13 1.96 
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Independent Variables  Weighted                       
 Adults  Unprotected  Protected         
Characteristics  n % n  % n % χ² df p-value UOR LL UL  




0.98 0.70 1.38 




1.07 0.83 1.37 




1.17 0.94 1.46 




1.17 0.84 1.62 




1.36 1.01 1.82 




1.21 0.82 1.79 




0.77 0.57 1.04 




0.64 0.35 1.16 




1.17 0.82 1.68 




1.19 0.98 1.44 




1.07 0.89 1.28 




0.74 0.44 1.25 




1.00 0.71 1.42 




0.97 0.72 1.30 




1.22 0.93 1.61 




0.58 0.43 0.78 




0.95 0.70 1.28 




0.84 0.62 1.13 




1.19 0.80 1.77 




1.09 0.82 1.44 




1.03 0.68 1.58 




0.77 0.48 1.22 




0.98 0.72 1.33 
 
  




   
113 
 
Independent Variables  Weighted                       
 Adults  Unprotected  Protected         
Characteristics  n % n  % n % χ² df p-value UOR LL UL  




   
Rural 5198 63.6 2978 57.3 2220 42.7 0.3 1 0.676 1   




1.02 0.92 1.15 




   




   
No education 865 10.6 368 42.5 497 57.5 177.1 3 0.001 1   




0.70 0.58 0.85 




0.45 0.36 0.55 




0.35 0.26 0.47 




   




   
Lowest 1517 18.6 898 59.2 619 40.8 3.7 4 0.715 1   




1.12 0.94 1.33 




1.10 0.90 1.35 




1.14 0.92 1.40 




1.11 0.94 1.31 









   
Bakongo Nord & Sud 625 7.7 349 55.9 276 44.1 29.4 7 0.023 1   




1.17 0.97 1.42 




0.87 0.69 1.10 




1.07 0.86 1.33 




0.91 0.66 1.25 




0.84 0.67 1.05 
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Independent Variables  Weighted                       
 Adults  Unprotected  Protected         
Characteristics  n % n  % n % χ² df p-value UOR LL UL  




0.88 0.73 1.06 




1.06 0.66 1.72 
 




   




   
Not Working 1926 23.6 1166 60.5 760 39.5 139.4 6 0.001 1   
Pro/tech/managerial 478 5.9 328 68.6 150 31.4 
 
 
 0.70 0.53 0.93 
Sales/clerical 1236 15.1 525 42.5 711 57.5 
 
 
 2.08 1.71 2.52 
Agriculture  3553 43.5 1962 55.2 1591 44.8 
 
 
 1.24 1.04 1.48 
HH/Domestic Service 583 7.1 411 70.5 172 29.5 
 
 
 0.64 0.48 0.85 
Manual laborer 231 2.8 179 77.5 52 22.5 
 
 
 0.44 0.28 0.70 
Army 162 1.9 92 56.8 70 43.2 
 
 
 1.15 0.71 1.87 




   




   
No Insurance 7799 95.5 4451 95.4 3348 95.5 0.0 1 0.938 1   




0.99 0.74 1.33 
 




   




   
Cannot read at all 2016 24.7 898 44.6 1118 55.4 189.9 3 0.000 1   




0.70 0.54 0.89 




0.49 0.43 0.56 




0.44 0.19 0.98 









   
Not Married  2510 30.7 1863 74.2 647 25.8 454.0 4 0.000 1   
115 
 
Independent Variables  Weighted                       
 Adults  Unprotected  Protected         
Characteristics  n % n  % n % χ² df p-value UOR LL UL  




2.71 2.34 3.13 




3.42 2.75 4.27 




3.38 2.30 4.95 




4.01 2.91 5.53 
           
 
 
    
Religion            
 
 
    
No Religion 118 1.4 80 67.7 38 32.3 16.8 5 0.001 1   




1.51 0.96 2.37 




1.56 0.98 2.49 




1.54 0.89 2.64 




1.70 1.07 2.70 











Descriptive Analysis & Bivariate Regression Model, Women 
Independent Variables  Weighted                      
Women Unprotected  Protected 
    
95% CI  
Characteristics  n  % n  % n % χ² df p UOR LCL UCL 
             
Women 4349 53.2 1502 34.5 2847 65.5       
             
Age (years)             
15-19 919 21.1 599 65.2 320 34.8 21.7 6 0.001 1   
20-24 854 19.6 299 35.0 555 65.0    1.35 0.83 2.2 
25-29 831 19.1 179 21.5 652 78.5    1.72 1.06 2.78 
30-34 570 13.1 93 16.3 477 83.7    2.70 1.53 4.77 
35-39 492 11.3 121 24.6 371 75.4    1.48 0.84 2.61 
40-44 359 8.3 100 27.9 259 72.1    1.01 0.58 1.76 
45-49 324 7.6 111 34.3 213 65.7    1.44 0.6 3.42 
             
Province              
Kinshasa 480 11.0 189 39.4 291 60.6 58.1 26 0.000 1   
Kwango 199 4.6 45 22.6 154 77.4    1.20 0.55 2.61 
Kwilu 293 6.7 80 27.3 213 72.7    0.91 0.48 1.73 
Mai-Ndombe 193 4.4 63 32.6 130 67.4    0.51 0.23 1.12 
Konho-Central 173 4.0 51 29.5 122 70.5    0.58 0.26 1.27 
Equateur 121 2.8 28 23.1 93 76.9    0.98 0.27 3.59 
Mongala 116 2.7 38 32.8 78 67.2    0.64 0.31 1.29 
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Independent Variables  Weighted                      
Women Unprotected  Protected 
    
95% CI  
Characteristics  n  % n  % n % χ² df p UOR LCL UCL 
Nord-Ubangi 67 1.5 17 25.4 50 74.6    0.34 0.13 0.92 
Sud-Ubangi 207 4.8 70 33.8 137 66.2    0.45 0.23 0.87 
Tshuapa 99 2.3 44 44.4 55 55.6    0.35 0.15 0.84 
Kasai 123 2.8 59 48.0 64 52.0    0.37 0.16 0.87 
Kasai-Central 181 4.2 56 30.9 125 69.1    0.80 0.36 1.78 
Kasai-Oriental 194 4.5 62 32.0 132 68.0    0.51 0.24 1.06 
Lomami 197 4.5 59 29.9 138 70.1    1.04 0.5 2.16 
Sankuru 72 1.7 29 40.3 43 59.7    0.41 0.14 1.18 
Haute-Katanga 176 4.0 68 38.6 108 61.4    0.45 0.17 1.2 
Haute-Lomami 98 2.3 30 30.6 68 69.4    0.62 0.29 1.31 
Lualaba 84 1.9 29 34.5 55 65.5    0.40 0.2 0.79 
Tanganika 76 1.7 40 52.6 36 47.4    0.20 0.1 0.38 
Maniema 136 3.1 53 39.0 83 61.0    0.35 0.17 0.75 
Nord-Kivu 406 9.3 158 38.9 248 61.1    0.46 0.23 0.91 
Bas-Uele 81 1.9 17 21.0 64 79.0    1.05 0.3 3.74 
Haute-Uele 77 1.8 27 35.1 50 64.9    0.46 0.22 0.95 
Ituri 134 3.1 57 42.5 77 57.5    0.31 0.1 0.94 
Tshopo 118 2.7 50 42.4 68 57.6    0.33 0.15 0.73 
Sud-Kivu 248 5.7 83 33.5 165 66.5    0.68 0.3 1.52 
             
Type of Residence             
Rural 2731 62.8 924 33.8 1807 66.2 9.3 1 0.002 1   
Urban 1618 37.2 578 35.7 1040 64.3    1.59 1.18 2.14 
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Independent Variables  Weighted                      
Women Unprotected  Protected 
    
95% CI  
Characteristics  n  % n  % n % χ² df p UOR LCL UCL 
             
Education             
No education 702 16.1 234 33.3 468 66.7 19.6 3 0.000 1   
Primary 1630 37.5 532 32.6 1098 67.4    1.13 0.83 1.54 
Secondary 1868 43 660 35.3 1208 64.7    1.90 1.34 2.67 
Higher 149 3.4 76 51.0 73 49.0    5.00 0.96 26.1 
             
Wealth Index             
Lowest 818 18.8 315 38.5 503 61.5 18.7 4 0.001 1   
Low 863 19.8 279 32.3 584 67.7    1.59 1.09 2.32 
Middle 880 20.2 274 31.1 606 68.9    1.69 1.15 2.49 
High 791 18.2 254 32.1 537 67.9    1.92 1.19 3.09 
Highest 997 22.9 380 38.1 617 61.9    2.34 1.52 3.58 
             
Ethnicity              
Bakongo Nord & Sud 348 8 124 35.6 224 64.4 21.8 7 0.003 1   
BasKasai & KwiluKwngo 731 16.8 196 26.8 535 73.2    1.31 0.71 2.41 
Cuvette Central 414 9.5 146 35.3 268 64.7    0.73 0.34 1.55 
Ubangi & Itimbiri 514 11.8 158 30.7 356 69.3    0.66 0.35 1.26 
Uele Lac Albert 320 7.4 124 38.8 196 61.3    0.51 0.23 1.13 
Basele-K, Man. & Kivu 821 18.9 309 37.6 512 62.4    0.65 0.34 1.24 
Kasai, Katanga, Tanganika 1144 26.3 423 37.0 721 63.0    0.71 0.39 1.31 
Lunda, Pygme, Other  57 1.3 22 38.6 35 61.4    0.42 0.18 0.98 
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Independent Variables  Weighted                      
Women Unprotected  Protected 
    
95% CI  
Characteristics  n  % n  % n % χ² df p UOR LCL UCL 
             
Occupation              
Not Working 1226 28.2 583 47.5 643 52.5 7.6 6 0.272 1   
Pro/tech/managerial 94 2.2 26 28.4 68 71.6    1.12 0.41 3.07 
Sales/clerical 921 21.2 273 29.6 648 70.4    0.99 0.63 1.53 
Agriculture  1875 43.1 532 28.4 1343 71.6    0.78 0.54 1.14 
HH/Domestic Service 123 2.8 36 29.3 87 70.7    1.58 0.74 3.37 
Manual laborer 18 0.4 6 33.3 12 66.7    0.27 0.06 1.27 
Army 92 2.1 46 50.0 46 50.0    0.80 0.2 3.21 
             
Health Insurance              
No Insurance 4143 95.3 1412 34.08 2731 65.9 29.8 1 0.281 1   
Insurance  206 4.7 90 43.69 116 56.3    1.55 0.7 3.43 
             
Literacy             
Cannot read at all 1575 36.2 516 32.8 1059 67.2 108 3 0.000 1   
Read part of sentence 431 9.9 144 33.4 287 66.6    0.70 0.54 0.89 
Read whole sentence 2324 53.4 835 35.9 1489 64.1    0.49 0.43 0.56 
Not Assessed  19 0.4 7 36.8 12 63.2    0.44 0.19 0.98 
             
Marital Status             
Not Married  1093 25.1 707 64.7 386 35.3 5.5 4 0.236 1   
Married 2049 47.1 477 23.3 1572 76.7    1.68 0.95 2.99 
120 
 
Independent Variables  Weighted                      
Women Unprotected  Protected 
    
95% CI  
Characteristics  n  % n  % n % χ² df p UOR LCL UCL 
Living with Partner 783 18 191 24.4 592 75.6    1.73 0.92 3.24 
Widowed/divorced  220 5.1 78 35.5 142 64.5    1.00 0.43 2.3 
Not Living with Partner  204 4.69 49 24.0 155 76.0    1.48 0.75 2.94 
             
Religion              
No Religion 36 0.8 9 25 27 75 9.7 5 0.084 1   
Catholic 1204 27.7 418 34.7 786 65.3    0.75 0.3 1.87 
Protestant 1193 27.4 402 33.7 791 66.3    0.77 0.28 2.08 
Local Religion 205 4.7 76 37.1 129 62.9    0.50 0.18 1.43 
Other - Christian 1669 38.4 580 34.8 1089 65.2    0.89 0.35 2.29 
Muslim 42 1.0 17 40.5 25 59.5    0.45 0.15 1.32 
             
Women births in the last 5 years           
No births 1767 40.6 960 54.3 807 45.7 269 4 0.000 1   
1 1153 26.5 289 25.1 864 74.9    3.55 2.84 4.44 
2 1135 26.1 211 18.6 924 81.4    5.21 4.11 6.61 
3 265 6.1 35 13.2 230 86.8    7.94 5.16 12.2 
4 29 0.7 7 24.1 22 75.9    3.51 1.21 10.2 
             
Prenatal visit to any provider             
No 294 11.4 100 34.01 194 66.0 18.4 1 0.000 1   
Yes  2287 88.6 441 19.28 1846 80.7    2.15 1.51 3.05 
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Independent Variables  Weighted                      
Women Unprotected  Protected 
    
95% CI  
Characteristics  n  % n  % n % χ² df p UOR LCL UCL 
Prenatal provider              
No visit 294 11 100 34.0 194 66.0 18.4 3 0.000 1   
Facility Based Staff 2204 85 428 19.4 1776 80.6    2.13 1.5 3.02 
Others 42 2 8 19.0 34 81.0    2.37 0.92 6.12 
Combined 41 2 6 14.6 35 85.4    3.32 0.93 11.9 
             
Women: Age at first child’s birth           
10-14  227 7.0 54 23.8 173 76.2 4.6 4 0.325 1   
15-19 1716 52.8 406 23.7 1310 76.3    0.76 0.45 1.29 
20-24 1015 31.3 226 22.3 789 77.7    0.83 0.47 1.48 
25-29 235 7.2 43 18.3 192 81.7    1.19 0.66 2.14 
30-42 54 1.7 17 31.5 37 68.5    0.49 0.19 1.28 
             
Women: Reported # TT before last child’s birth          
0 700 27 194 27.7 506 72.3 21.7 4 0.001 1   
1 to 2 1542 60 298 19.3 1244 80.7    1.60 1.23 2.07 
3 to 4 311 12 44 14.1 267 85.9    2.34 1.5 3.65 
5 + 19 1 5 26.3 14 73.7    1.08 0.38 3.08 
Do not know 11 0 2 18.2 9 81.8    1.66 0.17 16.2 
             
Women: # of TT before current preg           
0 747 51.2 205 27.4 542 72.6 9.5 4 0.049 1   
1 to 2 359 24.6 70 19.5 289 80.5    1.56 1.08 3.27 
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Independent Variables  Weighted                      
Women Unprotected  Protected 
    
95% CI  
Characteristics  n  % n  % n % χ² df p UOR LCL UCL 
3 to 4 188 12.9 32 17.0 156 83.0    1.85 0.98 3.48 
5 + 147 10.1 25 17.0 122 83.0    1.85 1.01 3.4 
Do not know 19 1.3 2 10.5 17 89.5    3.03 0.36 25.6 
             
Women: # years last received TT           
0-2 Years 241 33.8 31 12.9 210 87.1 4.5 2 0.105 1   
3-4 Years 245 34.3 47 19.2 198 80.8    1.98 1.05 3.74 
5+ years 228 31.9 52 22.8 176 77.2    1.26 0.67 2.35 
             
Women: Total children born             
0 1101 25.3 755 68.6 346 31.4 343 4 0.000 1   
1 to 2 1074 24.7 285 26.5 789 73.5    3.62 3.02 4.34 
3 to 4 860 19.8 164 19.1 696 80.9    4.35 3.58 5.29 
5 to 9 1164 26.8 251 21.6 913 78.4    3.45 2.92 4.06 






Descriptive Analysis & Bivariate Regression Model, Men  
Independent Variables  Weighted                     
  Men   Unprotected    Protected       p   95% CI 
Characteristics  n  % n  % n % χ² df value UOR LL UL  
             
Men 3820 46.8 3161 82.7 659 17.3       
             
Age (years)             
15-19 779 20.4 658 84.5 121 15.5 14.85 7 0.038 1   
20-24 623 16.3 500 80.3 123 19.7    1.35 0.93 1.97 
25-29 540 14.1 432 80.0 108 20.0    1.36 0.90 2.04 
30-34 475 12.4 373 78.5 102 21.5    1.49 0.96 2.30 
35-39 364 9.5 303 83.2 61 16.8    1.11 0.72 1.70 
40-44 357 9.3 317 88.8 40 11.2    0.69 0.43 1.12 
45-49 300 7.9 259 86.3 41 13.7    0.86 0.53 1.41 
50-59 382 10.0 319 83.5 63 16.5    1.08 0.71 1.65 
             
Province              
Kinshasa 395 10.3 317 80.3 78 19.7 56.59 25 0.001 1   
Kwango 175 4.6 155 88.6 20 11.4    0.51 0.25 1.02 
Kwilu 233 6.1 172 73.8 61 26.2    1.41 0.64 3.11 
Mai-Ndombe 183 4.8 156 85.2 27 14.8    0.72 0.42 1.23 
Konho-Central 141 3.7 125 88.7 16 11.3    0.50 0.25 1.02 
Equateur 128 3.4 106 82.8 22 17.2    0.82 0.56 1.20 
Mongala 100 2.6 78 78.0 22 22.0    1.13 0.68 1.87 
124 
 
Independent Variables  Weighted                     
  Men   Unprotected    Protected       p   95% CI 
Characteristics  n  % n  % n % χ² df value UOR LL UL  
Nord-Ubangi 64 1.7 49 76.6 15 23.4    1.35 0.76 2.37 
Sud-Ubangi 183 4.8 137 74.9 46 25.1    1.37 0.73 2.59 
Tshuapa 93 2.4 79 84.9 14 15.1    0.73 0.35 1.51 
Kasai 109 2.9 99 90.8 10 9.2    0.38 0.13 1.12 
Kasai-Central 157 4.1 126 80.3 31 19.7    1.00 0.46 2.16 
Kasai-Oriental 176 4.6 136 77.3 40 22.7    1.17 0.60 2.28 
Lomami 169 4.4 147 87.0 22 13.0    0.60 0.30 1.18 
Sankuru 67 1.8 61 91.0 6 9.0    0.36 0.13 0.97 
Haute-Katanga 153 4.0 122 79.7 31 20.3    1.05 0.61 1.82 
Haute-Lomami 98 2.6 85 86.7 13 13.3    0.62 0.31 1.22 
Lualaba 75 2.0 55 73.3 20 26.7    1.49 0.84 2.64 
Tanganika 67 1.8 60 89.6 7 10.4    0.38 0.16 0.90 
Maniema 118 3.1 97 82.2 21 17.8    0.87 0.44 1.74 
Nord-Kivu 327 8.6 297 90.8 30 9.2    0.40 0.22 0.74 
Bas-Uele 84 2.2 71 84.5 13 15.5    0.71 0.47 1.07 
Haute-Uele 78 2.0 59 75.6 19 24.4    1.28 0.72 2.27 
Ituri 117 3.1 86 73.5 31 26.5    1.45 0.76 2.73 
Tshopo 121 3.2 103 85.1 18 14.9    0.70 0.34 1.41 
Sud-Kivu 209 5.5 183 87.6 26 12.4    0.58 0.33 1.03 
             
Type of Residence             
Rural 2467 64.6 2054 83.3 413 16.7 0.64 1 0.424 1   
Urban 1353 35.4 1107 81.8 246 18.2    1.10 0.87 1.40 
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Independent Variables  Weighted                     
  Men   Unprotected    Protected       p   95% CI 
Characteristics  n  % n  % n % χ² df value UOR LL UL  
Education             
No education 163 4.3 134 82.2 29 17.8 11.86 3 0.008 1   
Primary 875 22.9 752 85.9 123 14.1    0.74 0.35 1.55 
Secondary 2462 64.5 2033 82.6 429 17.4    0.96 0.48 1.91 
Higher 320 8.4 242 75.6 78 24.4    1.45 0.64 3.31 
             
Wealth Index             
Lowest 699 18.3 583 83.4 116 16.6 4.30 3 0.366 1   
Low 751 19.7 633 84.3 118 15.7    0.95 0.64 1.39 
Middle 842 22.0 707 84.0 135 16.0    0.96 0.62 1.49 
High 726 19.0 598 82.4 128 17.6    1.09 0.76 1.55 
Highest 802 21.0 640 79.8 162 20.2    1.28 0.91 1.80 
             
Ethnicity              
Bakongo Nord & Sud 277 7.3 225 81.2 52 18.8 13.25 7 0.066 1   
BasKasai & KwiluKwngo 626 16.4 508 81.2 118 18.8    1.03 0.57 1.87 
Cuvette Central 404 10.6 338 83.7 66 16.3    0.87 0.53 1.44 
Ubangi & Itimbiri 488 12.8 385 78.9 103 21.1    1.19 0.72 1.96 
Uele Lac Albert 281 7.4 225 80.1 56 19.9    1.11 0.61 2.04 
Basele-K, Man. & Kivu 690 18.1 600 87.0 90 13.0    0.66 0.40 1.09 
Kasai, Katanga, Tanganika 1013 26.5 849 83.8 164 16.2    0.86 0.52 1.41 
Lunda, Pygme, Other  41 1.1 31 75.6 10 24.4    1.40 0.55 3.54 
             
Occupation              
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Independent Variables  Weighted                     
  Men   Unprotected    Protected       p   95% CI 
Characteristics  n  % n  % n % χ² df value UOR LL UL  
Not Working 700 18.3 583 83.3 117 16.7 14.87 6 0.021 1   
Pro/tech/managerial 384 10.1 302 78.6 82 21.4    1.36 0.89 2.10 
Sales/clerical 315 8.2 252 80.0 63 20.0    1.24 0.76 2.02 
Agriculture 1678 43.9 1430 85.2 248 14.8    0.87 0.63 1.19 
HH/Domestic Service 460 12.0 375 81.5 85 18.5    1.13 0.75 1.71 
Laborer 213 5.6 173 81.2 40 18.8    1.16 0.69 1.95 
Army 70 1.8 46 65.7 24 34.3    2.55 1.13 5.77 
             
Health Insurance              
No Insurance 3656 95.7 3039 83.1 617 16.9 5.63 1 0.018 1   
Insurance  164 4.3 122 74.4 42 25.6    1.70 1.09 2.62 
             
Literacy             
Cannot read at all 441 11.5 383 86.8 58 13.2 8.55 3 0.036 1   
Read part of sentence 310 8.1 253 81.6 57 18.4    1.47 0.76 2.86 
Read whole sentence 3051 79.9 2508 82.2 543 17.8    1.42 0.93 2.15 
Not Assessed  18 0.5 17 94.4 1 5.6    0.22 0.05 0.96 
             
Marital Status             
Not Married  1417 37.1 1156 81.6 261 18.4 2.53 4 0.638 1   
Married 1808 47.3 1511 83.6 297 16.4    0.87 0.71 1.07 
Living with Partner 440 11.5 368 83.6 72 16.4    0.87 0.59 1.27 
Widowed/divorced  59 1.5 50 84.7 9 15.3    0.73 0.30 1.75 
Not Living with Partner  96 2.5 76 79.2 20 20.8    1.15 0.60 2.20 
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Independent Variables  Weighted                     
  Men   Unprotected    Protected       p   95% CI 
Characteristics  n  % n  % n % χ² df value UOR LL UL  
             
Religion              
No Religion 82 2.1 71 86.6 11 13.4 4.47 5 0.484 1   
Catholic 1148 30.1 950 82.8 198 17.2    1.35 0.69 2.67 
Protestant 1062 27.8 890 83.8 172 16.2    1.26 0.63 2.54 
Local Religion 166 4.3 138 83.1 28 16.9    1.28 0.48 3.41 
Other - Christian 1307 34.2 1062 81.3 245 18.7    1.50 0.78 2.91 
Muslim 55 1.4 50 90.9 5 9.1       0.71 0.26 1.99 
 
 
